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Abstract
Heart disease remains the No.1 leading cause of death in U.S. and in the world. To improve
cardiac care services, there is an urgent need of developing early diagnosis of heart diseases and
optimal intervention strategies. As such, it calls upon a better understanding of the pathology of
heart diseases.
Computer simulation and modeling have been widely applied to overcome many practical and
ethical limitations in in-vivo, ex-vivo, and whole-animal experiments. Computer experiments
provide physiologists and cardiologists an indispensable tool to characterize, model and analyze
cardiac function both in healthy and in diseased heart. Most importantly, simulation modeling
empowers the analysis of causal relationships of cardiac dysfunction from ion channels to the
whole heart, which physical experiments alone cannot achieve.
Growing evidences show that aberrant glycosylation have dramatic influence on cardiac and
neuronal function. Variable but modest reduction in glycosylation among congenital disorders of
glycosylation (CDG) subtypes has multi-system effects leading to a high infant mortality rate. In
addition, CDG in all young patients tends to cause Atrial Fibrillation (AF), i.e., the most common
sustained cardiac arrhythmia. The mortality rate from AF has been increasing in the past two
decades. Due to the increasing healthcare burden of AF, studying the AF mechanisms and
developing optimal ablation strategies are now urgently needed.
Very little is known about how glycosylation modulates cardiac electrical signaling. It is also a
significant challenge to experimentally connect the changes at one organizational level (e.g.,
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electrical conduction among cardiac tissue) to measured changes at another organizational level
(e.g., ion channels). In this study, we integrate the data from in vitro experiments with in-silico
models to simulate the effects of reduced glycosylation on the gating kinetics of cardiac ion
channel, i.e., hERG channels, Na+ channels, K+ channels, and to predict the glycosylation
modulation dynamics in individual cardiac cells and tissues.
The complex gating kinetics of Na+ channels is modeled with a 9-state Markov model that have
voltage-dependent transition rates of exponential forms. The model calibration is quite a challenge
as the Markov model is non-linear, non-convex, ill-posed, and has a large parametric space. We
developed a new metamodel-based simulation optimization approach for calibrating the model
with the in-vitro experimental data. This proposed algorithm is shown to be efficient in learning
the Markov model of Na+ model. Moreover, it can be easily transformed and applied to many
other optimization problems in computer modeling.
In addition, the understanding of AF initiation and maintenance has remained sketchy at best.
One salient problem is the inability to interpret intracardiac recordings, which prevents us from
reconstructing the rhythmic mechanisms for AF, due to multiple wavelets’ circulating, clashing
and continuously changing direction in the atria. We are designing computer experiments to
simulate the single/multiple activations on atrial tissues and the corresponding intra-cardiac signals.
This research will create a novel computer-aided decision support tool to optimize AF ablation
procedures.

ix

Chapter 1 Background and Literature Review
1.1

Electrical Conduction System of Heart

The blood-pumping events of the heart are controlled by the electrical conduction system. As
shown in Figure 1-1, Pacemaker cells start a self-generating impulse with a rate of 60 to 100 beats
per minute (bpm) at the sinoatrial node (SAN) that is located at the border of Superior Vena Cava
and Right Atrium. This electrical impulse propagates through both atria to the Atrioventricular
(AV) node located in the floor of the Right Atrium. The AV node receives the electrical impulse
and transmits to the Bundle of His. The Bundle of His then divides into a right bundle branch and
two left bundle branches, which terminate at a complex network of Purkinje Fibers that spreads
throughout the ventricles. When impulse reaches the ventricles, the ventricular myocardium is
stimulated and contraction occurs.
The electrical impulse excites cardiac myocytes from resting states, and causes the flow of ions
in/out of cell membranes, which leads to the contractions of cardiac myocytes. In resting state,
sodium (Na+) ions stay outside of the cell and potassium (K+) ions stay inside of the cell. Because
the charge of Na+ ions is stronger than the K+ ions, the cell is polarized. When the stimulation
reaches, the Na+ ions move into the cell quickly through the ion channels. Then K+ ions flow out
of the cell through K+ channels, and at the same time, Calcium (Ca++) ions move slowly into the
cell through Ca++ channels. The flows of Na+, K+ and Ca++ ions depolarize the cell and start the
contraction (Phase 0). After the depolarization of the cell, the fast sodium channels close, and K+
ions start to move in and the Na+ ions start to move out, which causes an early repolarization
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(Phase 1). The slowly repolarization continues while Ca++ ions keep flowing into the cell slowly
(Phase 2). The Ca++ channels close after phase 2, and K+ ions move out of cell rapidly, at the
same time, K+ ions are transported to the inside of the cell, and Na+ ions are shipped outside of
the cell by potassium-sodium pump (Phase 3). The cell goes back to polarized state (Phase 4)
gradually and gets ready for another contraction. The action potential (AP) is a short-lasting event
in which the difference of membrane potential between the interior and the exterior of cardiac cells
raises and falls while the ions (i.e., Na+, K+, Ca++) flow through the cell membrane. Figure 1-2
shows a single cycle of AP. The AP rises to a positive value quickly (phase 0), and goes back to
resting potential (phase 4) gradually through phase 1-3.

HIS Bundle

Sinoatrial Node

Right Atrium
Left Atrium

Atrioventricular Node
(AVN)

Left Bundle Branch
(LBB)

Right Ventricle

Left Ventricle

Right Bundle Branch
(RBB)

Purkinje Fibers
(PF)

Figure 1-1 Cardiac conduction system.
2

1
2

3

0

4

4

Figure 1-2 Five phases in the cardiac action potential.
1.2

Glycosylation-Associated Cardiac Disease

As mentioned above, the net change of transmembrane potential in a cardiac myocyte during a
single contraction is produced by the orchestrated function of ion channels. A slight change in the
ion channel activity may affect AP waveforms and electrical conduction throughout the heart,
thereby potentially lead to severe cardiac disorder. Ion channels are heavily glycosylated with up
to 35% of a mature protein’s mass comprised of glycan structure [1]. It was shown that Na+ and
K+ channels can be extensively post-translationally modified by protein glycosylation through
isoform-specific mechanisms [2-5]. Typically, glycosylation-dependent gating effects were
imposed on ion channels primarily by the terminal residue attached to N- and O-glycan, sialic acid
[5-7]. Montpetit et al showed that cardiac glycome (i.e., the complete set of glycan structure
produced in the heart) varies between atria and ventricles, and changes differentially during the
development of each cardiac chamber [4]. In addition, the regulated expression of a single
glycosgene is shown to modulate AP waveforms and gating of less sialylated 𝑁𝑎𝑣 consistently [3].
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Growing evidence suggests that reduced glycosylation has dramatic effects on ion channels
gating and cardiac electrical signaling. There is a set of >40 distinct forms of inherited human
diseases of reduced glycosylation known as Congenital Disorders of Glycosylation (CDG) caused,
typically, by a mutation or deficiency in glycogene that results in a relatively modest reduction in
glycoprotein glycosylation [1, 8]. This variable but modest reduction in glycosylation among CDG
subtypes causes a high infant mortality rate. CDG patients often present with severe cardiac
deficits, but the mechanisms are not yet understood. Recently reported prevalence of cardiac
involvement prompted experts to suggest screening for cardiac dysfunction in all CDG patients
and for CDG in all young patients suffering from cardiomyopathy of unknown etiology.
1.3

Atrial Fibrillation

Atrial Fibrillation (AF) is the most common type of arrhythmia that affects more than 5 million
Americans. During AF, the atria beat chaotically and irregularly. The blood pools in the atria aren’t
pumped completely into the ventricles. As a result, the heart’s upper and lower chambers don’t
work cooperatively as they should. The AF occurs because the electrical signals of the heart are
not initiated in the SA node. Instead, they begin in the pulmonary veins or another part of atria.
These irregular signals spread throughout the atria in a rapid and disorganized way, and cause atria
to fibrillate. The impact of AF on healthcare systems is overwhelming, due to high risk of stroke,
increased mortality, impaired quality of life and hospitalization.
AF has three different stages: paroxysmal AF, persistent AF and Permanent AF. In paroxysmal
AF, abnormal electrical activities occur occasionally, and stop on their own. Episodes can be mild
or severe and last for seconds, minutes, hours or even days before stopping and returning back to
normal. Persistent AF cannot be stopped until some treatment interventions. It is usually caused
by frequent and over time rotors and wavelets. The treatments include pharmacological and
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catheter-based interventions. However, permanent AF is a very complex situation that cannot be
easily stopped by treatments.
Catheter ablation is an established treatment based on placement of lesions in the left and right
atrium with the goal of preventing abnormal activations. The location of the lesions can be
anatomically-based such as lines circled around the pulmonary veins. During the procedure,
physicians use the electrodes at the end of catheters to record electrical activity in the atria (i.e.,
intracardiac electrogram). Further, cardiologists pinpoint the potential AF sources and deliver
energy through the catheter to create incision lines that block faulty electrical pathways. The key
to a successful treatment is accurate identification and ablation of the abnormal signal and tissues.
However, the understanding of AF initiation and maintenance has remained sketchy at best. One
salient problem is the inability to interpret intracardiac recordings, which have thus far prevented
us from reconstructing the rhythmic mechanisms for AF. This makes the task of locating the
abnormal triggers very challenging. As a result, physicians often need to make ablation decisions
using ad hoc or heuristic strategies. There is an urgent need to realize the full potentials of
intracardiac electrograms for optimizing ablation decisions.
1.4

Modeling of Cardiac Electrical Signaling

Modeling and simulation provide more electrophysiological insights of cardiac electrical
signaling. A large amount of biological data has been generated over the past decades using
advanced technologies. These new generated data has overwhelmed our knowledge to understand
it. In many cases, the molecular, cellular, organ and system functions are unknown. Even when we
understand functions at genetic level, successful treatment and therapy depends on the knowledge
of how behaves at, e.g., molecular levels, interact with the rest of the relevant cellular function.
Without this integrative knowledge, it is difficult to identify which disease is relevant to a specific
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enzyme or transporter, and it is certainly difficult to know and control the side effects that are
unpredictable from molecular or cellular data alone. The interactions among different
organizational levels cannot be inspected alone with databases generated through physical
experiments. In order to understand the integrative properties of the system, we need to compute
the interactions of the properties within the whole biological system [10]. This provides
opportunities for analysis by simulation.
In the past decades, the iterative interaction between experiments and simulations benefit the
development of cardiac cell models greatly. Models have been built for all main type of cardiac
myocytes, and for some type of myocytes, multiple models exist. The current cardiac modeling
approaches can be generally categorized in to two groups as follows: The first group is
macro/minimal models such as cellular automata model, fitzHugh-Nagumo model and Barkley
Model. The second group is micro/maximal models, e.g., Hodgkin-Huxley model, Luo-Rudy
model, Rasmusson model and Nygren-Lindblad model [11-12]. The macro/minimal models do not
provide detailed ion physics, but they are easier to be incorporated into a large-scale system. The
micro/maximal models include hundreds of equations to describe the detailed ion channel
biophysics but increase the complexity of large-scale experiments. Alan Hodgkin and Andrew
Huxley first described how action potential in neurons are initiated and propagate with a
mathematical model (Hodgkin-Huxley model) in 1952. Based on Hodgkin-Huxley model, various
types of models, e.g., Purkinje fiber model, ventricular model, atrial model, of different animals,
e.g., mouse, pig, rabbit, were developed in the past 60 decades. Beeler and Reuter published the
first ventricular model with four ionic currents and 8 variables in 1977. Luo and Rudy improved
the Beeler and Reuter’s model with more experimental information, and formulated a modified
ventricular model (Phase 1 Luo-Rudy model) in 1991. In 1994, they further improved the model
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by reformulating and including more ion currents. Priebe and Beuckelman proposed a model of
human ventricular cells in 1998, and a reduced version of this model was proposed by Bernus et
al in 2002 [13]. In 2004, ten Tusscher et al formulated a new model for human ventricular cells
based on more experimental data, and this model is efficient for large-scale spatial simulations of
reentrant phenomena [14-15]. In addition, Iyer et al formulated a human left-ventricular epicardial
model. In Iyer’s model, there are 67 variables, and Markov models are applied to simulate gating
kinetics of some ion channels. Besides the human ventricular model, Rasmusson et al developed
a mathematical model of the action potential of mouse ventricular myocytes in 2004. This model
has been widely used to study the electrical signaling of mouse ventricular cells and the
electrophysiology of cardiac tissue [16]. In this current study, we also applied this model to
simulation the electrical activities of the heart across multiple physical scales such as ventricular
cells, 1D cell cables and 2D tissues.

Intracellular Medium

∅𝑖

𝐼𝑀

𝑉𝑚 = ∅𝑖 - ∅𝑖
𝐼𝑐
𝑉𝑚

𝐼𝑁𝑎
𝐺𝑁𝑎

𝐼𝐾

𝐼𝐿

𝐺𝐾

𝐺𝐿

𝑉𝐾

𝑉𝐿

𝐶𝑚
𝑉𝑁𝑎

∅𝑜

Extracellular Medium

Figure 1-3 The equivalent circuit of the Hodgkin-Huxley model.
7

The micro/maximal models of cardiac cells are built following similar principles, i.e., the
cardiac cell is modeled as a structured electric circuit with capacitors, resistors, and batteries. As
shown in Figure 1-3, the Hodgkin-Huxley model is constructed using the basic electric circuit
components of voltage source, resistance and capacitance [46]. The ion permeability of the
membrane for different ions, e.g. Na+, K+, is considered as the specific conductance per unit area.
Based on Ohm’s law, the model conductance can be formulated as [46]:
𝐺𝑁𝑎 =

𝐼𝑁𝑎
𝑉−𝐸𝑁𝑎

,

𝐺𝐾 =

𝐼𝐾
𝑉−𝐸𝐾

,

𝐺𝑁𝑎 =

𝐼𝐿
𝑉−𝐸𝐿

where 𝐺𝑁𝑎 , 𝐺𝐾 , 𝐺𝐿 are membrane conductance per unit area for Na+, K+ and leakage current; 𝐼𝑁𝑎 ,
𝐼𝐾 and 𝐼𝐿 are the corresponding ion currents; 𝑉𝑁𝑎 , 𝑉𝐾 and 𝑉𝐿 are the Nernst voltage for Na+, K+
and other ions; V is the action potential. The transmembrane current can be formulated as [46]:
𝐼𝑚 = 𝐶𝑚

𝑑𝑉
+ (𝑉 − 𝐸𝑁𝑎 )𝐺𝑁𝑎 + (𝑉 − 𝐸𝐾 )𝐺𝐾 + (𝑉 − 𝐸𝐿 )𝐺𝐿
𝑑𝑡

The conductance of Na+ ions can be calculated as:
𝐺𝑁𝑎 = 𝐺𝑁𝑎 𝑚𝑎𝑥 𝑚3 ℎ
𝑚 and ℎ can be obtained by the ordinary differential equations:
𝑑𝑚
𝑑𝑡

= 𝛼𝑚 (1 − 𝑚) − 𝛽𝑚 𝑚

𝑑ℎ
𝑑𝑡

= 𝛼ℎ (1 − ℎ) − 𝛽ℎ ℎ

where 𝛼’s and 𝛽’s are functions of V. The conductance of K+ ions can be calculated following the
similar way. Many modern neuronal and cardiac AP model were developed following similar basis
after Hodgkin-Huxley model. However, more ion currents are taken into consideration in the
models developed later. Figure 1-4 shows a schematic diagram of the dynamic Luo-Rudy (LRd)
ventricular cell model. This model includes a fast inward sodium current, an outward potassium
current, and a time-independent potassium current [47]. The Ten Tusscher et al modeled and the
Bondarenko et al model describe the electrophysiology of cardiac cells following the same
8

schemes, but have more transmembrane currents. The relatively detailed models enable a more
accurate interpretation of the cellular mechanisms.
𝑰𝒃

𝑰𝑵𝒂

𝑰𝒔𝒊

𝑵𝒂+

𝑲+

𝑰𝑲

𝑰𝑲𝟏

𝑰𝑲𝒑

Figure 1-4 Schematic diagram of the dynamic Luo-Rudy (LRd) ventricular cell model.

The activities of tissue are like a functional syncytium of electrically coupled cells. The tissue
can be simulated as a resistor network, and the electrical propagation among tissue can be
considered as an excitable medium in 1D, 2D and 3D. Among this excitable medium, i.e. cardiac
tissues, cells are coupled diffusively through the transmembrane voltage. There are two types of
tissue models: bidomain model and monodomain model. In bidomain model, cardiac tissue is
simulated as a syncytium composed of intracellular and extracellular domains. It simulates the
current flow, distribution of electrical potential and the conservation of charge and current [17, 48]:
∇ ∙ 𝐆𝐢 (∇𝑉𝑚 + ∇∅𝑒 ) = 𝛽𝑚 (𝐶𝑚

𝜕𝑉𝑚
+ 𝑖𝑖𝑜𝑛 )
𝜕𝑡

∇ ∙ ((𝐆i + 𝐆e )∇∅𝑒 ) = −∇ ∙ (𝐺𝑖 ∇𝑉𝑚 )
9

where 𝑉𝑚 is the membrane potential, 𝐆i and 𝐆e are conductivity tensors determined by the
anisotropy of cardiac tissues. Their components depend on the conductivities and local orientation
of cardiac tissue in the coordinate system of the model.
The monodomain model assumes the anisotropy of the intracellular and extracellular spaces is
the same. It describes the membrane potential (𝑉𝑚 ) with a partial differential equation [18, 48]:
𝜕𝑉𝑚
𝑖𝑖𝑜𝑛
= ∇ ∙ 𝐃∇𝑉𝑚 −
𝜕𝑡
𝐶𝑚
where 𝐃 is a diffusion tensor or scalar diffusion coefficient:
𝑫 = 𝐷2 𝐈 + (𝐷1 − 𝐷2 )𝐟𝐟 𝑻
where 𝐷1 is the longitudinal coefficient for propagation along fibers, 𝐷2 is a transverse coefficient
for propagation orthogonal to the fibers if the fiber direction is given by vector 𝐟.
Monodomain and bidomain models have been demonstrated to be very close when there is no
injection of current into the extracellular space [19, 48]. Potse et al. compared the patterns of action
potential propagation simulated using monodomain and bidomain models. They found the patterns
obtained from both models were almost identical when there is not external stimulation [20].
Similarly, Roth simulated spiral wave tip trajectories with both bidomain and monodomain models.
The study showed similar trajectories in the two cases [21]. The monodomain model is preferred
when there are no external stimuli because monodomain models are numerically easier to be solved.
However, bidomain models are necessary when currents are injected into the extracellular space
during the external stimulation and defibrillation [22]. While simulating defibrillation, it is
important to consider the unequal anisotropy of the intracellular and extracellular spaces, because
the virtual electrodes generated are critical for successful defibrillation [23]. The bidomain models
can be expanded to higher domains, for example Sachse et al. applied bidomain model to
fibroblasts by adding an additional domain [24].
10

Modeling the functional relationship between the discrete structure and integrated functions of
heart at microscope and macroscope are quite challenging. Different assumptions and
simplifications are made while building models of cardiac cells and tissues. There is no general
framework for simulating cellular electrophysiology, tissue electrical activity, and geometrical
features. There are still many open questions to be answered. For example, there are no well
adapted parameters for determining the patterns of APs in cardiac cells and the propagation of APs
among tissues. More work need to be done to efficiently establish the biophysical basis for these
parameters and to understand the sensitivity of these parameters to cell and tissue activities. In
addition, it is essential to integrate models with experimental data to simulate and predict disease
mechanisms and treatment effects. However, many of the models are difficult to calibrate to
simulate the physical data, and many phenomena investigated using tissue models are difficult to
verify experimentally. Representation of pathological function is still challenging because robust
methods and parameters to represent the disease conditions such as arrhythmias and infarction
have not been fully developed. This study makes efforts to address the challenges and answer all
these open questions in the cardiac modeling area.
1.5

Simulation Optimization

Simulation optimization finds the optimal input variables from all potential candidates without
explicitly evaluating each possible set of variables. In simulation optimization, the output of a
simulation model is used by the optimization method to evaluate the performance of each search
for the optimal solution, and provide feedback to the search thereby guiding further input to the
simulation model. There are six major types of simulation optimization methods: Gradient Based
Search Methods, Stochastic Optimization, Response Surface Methodology (RSM), Heuristic
Methods, A-Teams and Statistical Methods [25]. Gradient based search methods estimate the
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gradient of the response function (∇f) to learn the shape of the objective function. The optimal
solution is searched with deterministic mathematical programming approaches. Finite differences
[26], likelihood ratios [27] and perturbation analysis [28] are some common methods for gradient
search optimization methods. Stochastic optimization applies stochastic approaches to estimate or
measure the value of the objective functions that cannot be evaluated analytically. Conventionally
it is an iterative schemes based on gradient estimation. Some stochastic optimization algorithms
can be found in [29-33]. Heuristic methods, e.g., Genetic Algorithms [34], Evolutionary Strategies
[35], Simulated Annealing [36, 37], Tabu Search [38, 39], Nelder and Mead’s Simplex Search and
A-Teams [40], include a set of direct search methods for finding the optimal solutions. Statistical
methods basically simulate the system under a number of measurements underlying some
probability distributions, and it includes Importance Sampling and Ranking and Selection. RSM
method generally is to obtain an approximation in terms of functions between the input variables
and the output objective function, i.e., response. The approximation of the response on the entire
domain of interest is conventionally called metamodel. This metamodel can be different types of
model, for example, regression model and neural network models. Once the metamodel is
established, the estimated optimum can be evaluated using appropriate deterministic optimization
procedures. However, RSM is not always applied for optimization purpose. Sequential RSM is
sometimes used to determine a search strategy, for example to find the best next point.
In the simulation optimization community there is a long history of research on experiment
design for applying metamodels to replace the time-consuming simulation model. Metamodels
serve as surrogate models that approximate the input/output functions defined by computer
experiments. It has been illustrated to be sufficient in locating the optimum solution. In simulation
optimization polynomial regression models are applied to fit the response surface of the system of
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interest [41]. In addition, the krigging methodology becomes increasingly popular and has been
quite successful for investigating uncertainties of the unknown response in computer experiments
[42]. Many previous studies focused on the application of krigging model, e.g. Gaussian Process
(GP) model, for calibrating computer models in the engineering domain, e.g., Kennedy and
O’Hagan [43], Qian and Wu [44], and Chang and Joseph [45]. However, little has been done in
the cardiovascular domain. Calibrating cardiac models is not a straightforward application of
aforementioned works, due to nonlinear/non-convex characteristics of models and different types
of function responses. In particular, calibrating cardiac models needs to specifically consider the
kinetics and physical properties of ion channels, cells, tissues, and the heart. This investigation
made one of the first attempts to bridge the gaps in statistical metamodeling between engineering
and cardiac domains.
1.6
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Chapter 2 In-Silico Modeling of Glycosylation Modulation Dynamics in hERG Ion
Channels and Cardiac Electrical Signals1
Cardiac action potentials (AP) are produced by the orchestrated functions of ion channels. A
slight change in ion channel activity may affect the AP waveform, thereby potentially increasing
susceptibility to abnormal cardiac rhythms. Cardiac ion channels are heavily glycosylated, with up
to 30% of a mature protein’s mass comprised of glycan structures. However, little is known about
how reduced glycosylation impacts the gating of hERG (human ether-a-go-go related gene)
channel, which is partially responsible for late phase 2 and phase 3 of the AP. This study integrates
the data from in vitro experiments with in-silico models to predict the glycosylation modulation
dynamics in hERG ion channels and cardiac electrical signals. The gating behaviors of hERG
channels were measured under four glycosylation conditions, i.e., full glycosylation, reduced
sialylation, mannose-rich. And N-glycanase treated. Further, we developed in-silico models to
simulate glycosylation-channel interactions and predict the effects of reduced glycosylation on
multi-scale cardiac processes (i.e., cardiac cells, 1-D and 2-D tissues). From the in-silico models,
reduced glycosylation was shown to shorten the repolarization phase of cardiac APs, thereby
influencing electrical propagation in cardiac fibers and tissues. In addition, the patterns of derived
electrocardiogram show that reduced glycosylation of hERG channel shortens the QT interval and
decreases the re-entry rate of spiral waves. This work suggests new pharmaceutical targets for the
long QT syndrome and potentially other cardiac disorders.

1

This chapter was published in IEEE Journal of Biomedical and Health Informatics [32]. Permission is included in Appendix A.
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2.1

Introduction

Glycosylation is a common enzymatic process in cardiac cells. It was shown that nearly 30%
of a mature protein’s mass is comprised of glycan structures [1]. It is established that voltage-gated
Na+ channels (𝑁𝑎𝑣 ) and K + channels (𝐾𝑣 ) are also known to be modulated by posttranslational
glycosylation through isoform-specific mechanisms [2-5]. Many previous studies showed that
glycosylation-dependent gating effects were imposed on ion channels primarily by the terminal
residue attached to N- and O-glycans, sialic acid [5-7]. The addition and removal of glycans from
proteins and lipids are completed by the activity of >200 glycosidases, glycosyltransferases, and
transport proteins (glycogenes). Recently, Montpetit et al. showed that the cardiac glycome (i.e.,
the complete set of glycan structures produced in the heart) varies between atria and ventricles,
and changes differentially during development of each cardiac chamber [4]. Regulated expression
of a single glycogene was sufficient to modulate action potential (AP) waveforms and gating of
less sialylated 𝑁𝑎𝑣 consistently [3].
In addition to the evidence that a correctly regulated glycome is vital to normal cell function,
aberrant glycosylation has dramatic effects on the cardiac function. There is a set of >40 distinct
forms of inherited human diseases of reduced glycosylation known as Congenital Disorders of
Glycosylation (CDG) caused, typically, by a mutation or deficiency in a glycogene which results
in a relatively modest reduction in glycoprotein glycosylation [8, 9]. This variable but modest
reduction in glycosylation among CDG subtypes causes a high infant mortality rate. Recently
reported prevalence of cardiac involvement prompted experts to suggest screening for cardiac
dysfunction in all CDG patients and for CDG in all young patients suffering from cardiomyopathy
of unknown etiology. Together, the literature suggests that regulated and aberrant changes in
glycosylation impact cardiac function.
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However, little is known about how altered glycosylation will impact cardiac function at
different organization levels, i.e., from ion channels to cells to tissues to the whole heart.
Corroborating data that connects the changes in multi-scale cardiac systems is difficult without
performing computer simulations. There is an urgent need to couple the wealth of data obtained
from in-vitro and in-vivo experiments with in-silico models. Computer model overcomes practical
and ethical limitations in the in-vivo experiments. In addition, it enables the prediction of causal
relationships between normal or abnormal functions (e.g., glycosylation modulation dynamics)
that in-vivo experiments alone cannot easily achieve.
Our objective is to investigate how changes in glycosylation influence the hERG (i.e., human
ether-a-go-go related gene) ion channels and cardiac electrical signaling from cells to cables, and
to tissues. In this present study, we developed in-silico models of cardiac cells and tissues to study
the role of glycosylation in cardiac function. The hERG channel mediates the rapid delayed
rectifying potassium current (𝐼𝐾𝑟 ), which is partially responsible for late phase 2 and phase 3 of
the AP, i.e., the repolarization of cardiac myocytes [10]. The "gain" or “loss” in the hERG channel
function can potentially lead to the Short or Long QT syndromes [11]. Our contribution is to
integrate the data from in-vitro experiments with in-silico models for predicting the effects of
reduced glycosylation on cardiac function. The purpose of this article is to model the glycosylation
effects on ion channels, and further predict its impacts at larger scales, i.e., from cells to tissues.
2.2

Multi-Scale Cardiac Modeling

Computer models facilitate the quantitative simulation, elucidation and understanding of
cardiac function in health and disease. The need to integrate models and data across multiple
biological scales has been widely recognized by biomedical and clinical researchers [12, 13]. This
present investigation integrates glycosylation-channel interactions, obtained from the whole-cell
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patch clamp experiments, with in-silico models to predict glycosylation modulation dynamics in
hERG channels and cardiac electrical signals including ionic currents, action potentials, spiral
waves, and ECG signals. The development of multi-scale cardiac models, i.e., hERG channel, cell,
and tissues, is described as follows.
2.2.1 Model of hERG Channel
The hERG channel is widely modeled in two forms. One is the Hodgkin-Huxley (HH) type
model, and the other is Markov state model. The HH type formulation typically describes the
gating of hERG channel with two independent activation and inactivation variables, as shown in
the following equations:
𝐾𝑜
𝐼𝐾𝑟 = 𝐺𝐾𝑟 √ 𝑋𝑟1 𝑋𝑟2 (𝑉 − 𝐸𝐾 )
5.4
1

𝑋𝑟1∞ =
1+𝑒

−

𝑋𝑟2∞ =

(𝑉−𝑉𝑎 )
𝐾𝑎

1
1+𝑒

(𝑉−𝑉𝑖 )
𝐾𝑖

where 𝑉 is the trans-membrane action potential, 𝐾𝑜 =5.4mM is the extracellular K+ concentration,
𝐸𝐾 is the reversal potential, 𝐺𝐾𝑟 is the conductance (nS/pF), 𝑋𝑟1∞ is the steady-state activation,
𝑋𝑟2∞ is the steady-state inactivation, 𝑉𝑎 is the voltage of half-activation, 𝑉𝑖 is the voltage of halfinactivation, 𝐾𝑎 and 𝐾𝑖 are slope factors.
Despite the popularity of HH-type descriptions, Markov models have become increasingly
important in recent years. There are a number of Markov models developed with different states
and structures, e.g., Wang et al. [14], Clancy and Rudy [15], Mazhari et al. [16], and Oehmen et
al. [17]. In 2011, Bett et al. compared the HH type formulation with the aforementioned four
Markov models. The conclusion is that hERG is best represented by a linear Markov model with
3 closed states, one open and one inactivated state [18]. Hence, we adopted the 5-state Markov
formulations to model the gating of hERG channel. As shown in Figure 2-1, the Markov model
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includes 3 closed states (C1, C2, C3), 1 inactivation (I) and 1 open (O) state. The transition rates
(𝛼’𝑠 and 𝛽’𝑠) are voltage-dependent, i.e., 𝛼 = 𝑎𝑖 × 𝑒 𝑏𝑖 ∙𝑉 and 𝛽 = 𝑐𝑖 × 𝑒 𝑑𝑖 ∙𝑉 , wherer 𝑖 is the index
of transition rate parameters. The constants, Kf and Kb, describe the voltage insensitive transition
in the gating of hERG channel. ᴪ is defined as a function of other transition rates to ensure the
microscopic reversibility [16, 18]. The hERG channel stays in the fully closed state (C1) during
resting, and transfers to other states when excited. The initial value of C1 = 1, and others are 0.
O

𝐼𝐾𝑟 = 𝐺𝐾𝑟 𝑂(𝑉 − 𝐸𝐾 )

αi3

α1

Kf
C2
C1
β1
𝑰𝑲𝒓 = 𝑮𝑲𝒓𝑶(𝑽
− 𝑬𝑲 Kb

C3

ᴪ

αi
βi

α2
β2

I

Figure 2-1 Structure of 5-state Markov model of hERG channel.

2.2.2 Model of Cardiac Myocyte
When a cardiac myocyte is stimulated, the states of ion channels (e.g., close, activation,
inactivation) control the ability of the ions (e.g., 𝑁𝑎 + , 𝐶𝑎++ , and 𝐾 + ) to cross the membrane. The
influx and efflux of ions generate electrical currents through the ion channels, and vary transmembrane potentials. The cardiac cell is modeled as a structured electric circuit with capacitors,
resistors and batteries. Specific to human ventricular cells, a number of models have been
developed in the literature, e.g., Priebe and Beuckelmann model [19], ten Tusscher-Panfilov 2004
model [20] and the updated 2006 model [21], Iyer et al. model [22], Grandi et al. model[23], and
O’Hara et al. model [24].
In this present investigation, we utilized ten Tusscher-Panfilov 2006 model to describe the
electrophysiological behaviors of human ventricular myocytes [21]. The justification is that the
results of ten Tusscher-Panfilov 2006 model best match our wild-type data (i.e., full glycosylation)
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from in-vivo experiments. The major updates from the ten Tusscher-Panfilov 2004 model to the
2006 version are the inclusion of more detailed description of intracellular Ca++ dynamics and
subspace Ca++ dynamics, as well as the revisions of fast and slow voltage inactivation gate in 𝐼𝐶𝑎𝐿 .
The endocardial-cell version of ten Tusscher-Panfilov 2006 model is used to simulate the AP
(𝑉) with the following ordinal differential equation:
−𝐶𝑚

𝑑𝑉
= 𝐼𝑡𝑜 + 𝐼𝐾𝑠 + 𝐼𝐾𝑟 + 𝐼𝐾1 + 𝐼𝑁𝑎𝐶𝑎 + 𝐼𝑁𝑎𝐾 + 𝐼𝑝𝐾 + 𝐼𝑝𝐶𝑎 + 𝐼𝑏𝐶𝑎
𝑑𝑡
+𝐼𝑏𝑁𝑎 + 𝐼𝑁𝑎 + 𝐼𝐶𝑎𝐿 + 𝐼𝑠𝑡𝑖𝑚

where 𝑡 is time, 𝐶𝑚 is the cell capacitance per unit surface area, 𝐼𝑠𝑡𝑖𝑚 is the external stimulus
current which activates the cell from the resting state. The transmembrane currents include
transient outward current (𝐼𝑡𝑜 ), slow delayed rectifier 𝐾 + current (𝐼𝐾𝑠 ), rapid delayed rectifier 𝐾 +
current (𝐼𝐾𝑟 ), inward rectifier current (𝐼𝐾1 ), 𝑁𝑎+ /𝐶𝑎++ exchange current (𝐼𝑁𝑎𝐶𝑎 ), pump current
(𝐼𝑁𝑎𝐾 ), plateau currents (𝐼𝑝𝐾 , 𝐼𝑝𝐶𝑎 ), background currents (𝐼𝑏𝐶𝑎 , 𝐼𝑏𝑁𝑎 ), fast Na+ current (𝐼𝑁𝑎 ) and Ltype 𝐶𝑎++ current (𝐼𝐶𝑎𝐿 ). Most of these voltage-gated ionic currents are modeled in the form of
cell conductance, membrane potential gradients and channel gate dynamics. The details of all ionchannel kinetics can be found in references [20, 21]. All parameters and initial values are the same
as given in the ten Tusscher-Panfilov 2006 model. Note that we replaced the HH type model of
𝐼𝐾𝑟 with the 5-state Markov model. The 𝐺𝐾𝑟 is the same as the original value in ten TusscherPanfilov model. We optimally calibrated the 5-state Markov model to fit the in-vivo data of four
glycosylation conditions from our in-vivo experiments.
2.2.3 Model of Cardiac Tissue
The cardiac cell is not an independent unit. Each depolarized cell can stimulate neighboring
cells and trigger cell-to-cell conductions. In the rapid depolarization phase, the overshoot of 𝑁𝑎+
ions causes a resting-to-depolarizing 𝑁𝑎 + gradient and drives the flow of 𝑁𝑎+ through gap
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junctions that stimulates adjacent cells. The influx of 𝑁𝑎 + causes neighboring cells to reach
threshold potential and initiates the depolarization phase of the AP. As the depolarization and
repolarization propagate among cells, electrical waves are generated. This cell-to-cell conduction
is analogous to a circuit system with resistances and capacitors. As shown in Figure 2-2, the
consecutive cell connections are modeled as linear fiber (cable) and tissue (cell array). The 1D
linear cable is composed of 600 cells, and a stimulus is given at cell 1. The linear strand of cells
(i.e., cable) is modeled using the following mono-domain reaction-diffusion equation:
𝜕𝑉
1
1 𝜕 2𝑉
(𝐼𝑖𝑜𝑛 + 𝐼𝑠𝑡𝑖𝑚 ) +
=−
𝜕𝑡
𝐶𝑚
𝜌𝑆𝐶𝑚 𝜕𝑥 2
and in 2D tissue, the equation is:
𝜕𝑉
1
1
𝜕 2𝑉 𝜕 2𝑉
(𝐼𝑖𝑜𝑛 + 𝐼𝑠𝑡𝑖𝑚 ) +
=−
( 2+
)
𝜕𝑡
𝐶𝑚
𝜌𝑆𝐶𝑚 𝜕𝑥
𝜕𝑦 2
where 𝐼𝑖𝑜𝑛 is the sum of trans-membrane ion currents, 𝜌 = 180Ω𝑐𝑚 is the cellular resistivity, 𝑆 =
0.2 𝑢𝑚−1 is the surface-to-volume ratio, and 𝐶𝑚 = 2 𝑢𝐹/𝑐𝑚2 is the cell capacitance.
To simulate the propagation of cardiac electrical waves along 1D fiber, reaction-diffusion
equations are numerically solved with the finite-difference scheme. The action potential can be
calculated as:
𝑉𝑖𝑡+𝑑𝑡 = −
where 𝑞 =

𝑑𝑡
𝜌𝑆𝑑𝑥 2

𝑑𝑡
2𝑞
𝑞
𝑡
(𝐼𝑖𝑜𝑛 + 𝐼𝑠𝑡𝑖𝑚 ) − ( − 1) 𝑉𝑖𝑡 +
(𝑉 𝑡 + 𝑉𝑖+1
)
𝐶𝑚
𝐶𝑚
𝐶𝑚 𝑖−1

is the same for all cells. Neuman boundary condition was assumed in the

𝑡
𝑡
simulation of 1D cardiac cable, i.e. 𝑉101
= 𝑉99
and 𝑉0𝑡 = 𝑉2𝑡 at the boundaries. The numerical

finite-difference scheme for 2D tissue is formulated as:
𝑡+𝑑𝑡
𝑉𝑖,𝑗
= −

𝑑𝑡
4𝑞
𝑞
𝑡
𝑡
𝑡
𝑡
(𝐼𝑖𝑜𝑛 + 𝐼𝑠𝑡𝑖𝑚 ) − ( − 1) 𝑉𝑖,𝑗
+
(𝑉 𝑡 + 𝑉𝑖+1,𝑗
+ 𝑉𝑖,𝑗−1
+ 𝑉𝑖,𝑗+1
)
𝐶𝑚
𝐶𝑚
𝐶𝑚 𝑖−1,𝑗

where no flux boundary condition is assumed to ensure there are no current leakages on the borders.
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Figure 2-2 Structures of 1D fiber and 2D tissues.

2.2.4 ECG Derivation
The ECG signal provides a system-level view of cardiac electrical activity, which is an
important clinical diagnostic tool. The standard lead I, II and III (i.e., Einthoven's triangle) measure
difference in potentials between electrodes placed on left arm, right arm and left leg [25]. In this
study, 3-lead ECG signals are measured using 3 virtual electrodes in an equilateral triangle on 2D
tissues. The ECG will be used to evaluate and quantify whether and how altered glycosylation
affects cardiac electrical conduction. In this investigation, the electrodes were placed at a distance
of 6 cm above 2D tissues with no-flux boundary conditions. The potential at each electrode is
calculated using the following equation:
∅=∬
𝑆

𝐼𝑖𝑜𝑛
𝑑𝑥𝑑𝑦
𝑟

where 𝑆 is the area over cardiac tissue, 𝑖𝑖𝑜𝑛 is the transmembrane currents, 𝑥 and 𝑦 represent the
coordinates of cells on 2D tissue, and 𝑟 is given as:
𝑟 = √(𝑥 − 𝑥𝐸 )2 + (𝑦 − 𝑦𝐸 )2 + 𝑧𝐸 2
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where 𝐸 = (𝑥𝐸 , 𝑦𝐸 , 𝑧𝐸 ) is the location of the electrode. The 𝐼𝑖𝑜𝑛 current is obtained with the
following equation:
𝐼𝑖𝑜𝑛

1
𝜕 2𝑉 𝜕 2𝑉
=
(
+
)
𝜌𝑆𝐶𝑚 𝜕𝑥 2
𝜕𝑦 2

Lead I, II, III ECG signals are the potential differences between two electrodes as:
𝐸𝐶𝐺(𝐸1 , 𝐸2 ) = ∅(𝑥𝐸1 , 𝑦𝐸1 , 𝑧𝐸1 ) − ∅(𝑥𝐸2 , 𝑦𝐸2 , 𝑧𝐸2 )
It may be noted that 60o orientation is considered between each two leads.
2.3

Materials and Experimental Design

2.3.1 Physical Experiments
We recently reported the effects of differential glycosylation on the gating of hERG ion
channels, showing that N-glycosylation effectively limits the hERG activity [26, 27]. The in-vitro
experimental data were collected from hERG-expressing CHO cells under 4 glycosylation
conditions, i.e., full glycosylation (n = 11), reduced sialylation (n = 11), mannose-rich
glycosylation (n = 6) and N-Glycanase treated (n = 6). Steady-state gating parameters were
examined with the use of standard pulse protocols and solutions described by the Bennett lab [26].
Steady State Activation (SSA) protocol is described as follows. Cells were held at -80 mV,
stepped to more depolarized potentials (-80 mV to +40 mV in 10 mV increments) for 4 seconds,
then stepped back to -50 mV for another 4 seconds, and returned to the holding potential. Steadystate conductance values (𝐺) were calculated using ohm’s law 𝐺 = 𝐼/(𝑉𝑝 − 𝐸𝐾 ), where 𝐼 is the
peak of tail currents elicited at each test potential (𝑉𝑝 ). The maximum conductance generated by
each cell was used to normalize the data for each cell to its maximum conductance by fitting the
data to a single Boltzmann distribution as:
Fraction of maximal conductance = [1+exp(-(V-Va)/Ka]]-1
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where V is the membrane potentials, Va is the half-activation potential, K a is the slope factor. The
normalized data were averaged with those from the other cells to calculate the resulting average
G-V curves.
Steady state inactivation (SSI) is measured following a conventional protocol. Cells were held
at -80 mV before stepping to +20 mV for 3 seconds. Then we stepped to -120 mV to +60 mV (in
10 mV increments) for 30ms before stepping back to +20 mV for 1 second and then returned to
the resting potential. The maximum current generated by each cell was used to normalize the data
for each cell to its maximum current by fitting the data to a single Boltzmann distribution, from
which the mean Vi ±SEM and Ki ±SEM values were determined.
Fraction of maximal current = [1+exp ((V-Vi)/Ki)]-1
where V is the membrane potential, Vi is the voltage of half-inactivation, Ki is the slope factor.
Table 2-1 shows the mean ± SEM SSA and SSI parameters measured under four glycosylation
conditions, as reported by us previously [26] . These changes in hERG channel gating were used
to calibrate in-silico models, which further predict glycosylation effects on cardiac electrical
signaling of cells and tissues.
Table 2-1 hERG channel activation and inactivation parameters [26].
hERG Channel

n

Va(mV)

Ka(mV)

Vi(mV)

Ki(mV)

Full Glycosylation

11

-22.0±1.3

8.4±0.3

-74.4±4.9

-19.0±0.8

Reduced Sialylation

11

-13.7±2.4

8.6±0.4

-56.2±5.3

-17.2±1.3

Mannose-Rich

6

-12.6±2.4

8.9±0.4

-51.48±3.6

-16.4±0.9

N-Glycanase treated

6

-12.1±2.2

8.9±0.9

-58.5±5.9

-20.3±1.2

2.3.2 Computer Experiments
Recall that we modeled the hERG channel with a 5-state Markov formulation, as opposed to
the traditional HH type formulation. First, the Markov model was calibrated and fitted to
26

glycosylation data from in-vivo experiments (see Table 2-1). The sensitivity analysis is performed
to establish model parameters that maximally influence the output for each protocol. Furthermore,
the algorithm of nonlinear constrained optimization is used to find the parameter values
minimizing the sum of the least-square errors between model predictions and experimental data in
glycosylation. Pulse protocols used in in-silico models are the same as in in-vivo experiments.
Second, we simulated and compared the variations of 𝐼𝐾𝑟 currents and APs for four glycosylation
conditions. The glycosylation-induced variations in hERG channels were modeled to predict the
changes of 𝐼𝐾𝑟 magnitudes and action potential durations (APDs). Third, cardiac cells were
connected by gap junctions in a linear fiber, i.e., cable, to predict the glycosylation effects on AP
propagation, assuming that altered glycosylation impacts hERG channel gating only. The
inhomogeneous cable contains 600 cells, in which 300 cells are fully glycosylated and the other
300 cells are under one of three conditions of reduced glycosylation (i.e., reduced sialylation,
mannose-rich, or N-Glycanase treated)., Further, we measured the APD restitution curves for 4
glycosylation conditions in the 1D cable of cardiac cells. Finally, we construct the model of 2D
tissues by arranging cardiac cells in an array (see Figure 2-2). Glycosylation effects on the
rectilinear and spiral waves were predicted using in-silico simulation models. In addition, ECG
signals were derived to characterize the variations of cardiac electrical conduction between full
glycosylation and reduced glycosylation.
In the single cell, we used a 2-ms 38 pA/pF stimulus current (𝐼𝑠𝑡𝑖𝑚 ) applied at a frequency of
0.5~2 Hz to trigger simulated APs. The 𝐼𝐾𝑟 currents and AP were obtained after at least 100 cycles
when the cell reached steady states. The variable temporal resolution is used in the single-cell
simulation. In the linear cable, the 𝐼𝑠𝑡𝑖𝑚 amplitude of 52 pA/pF and spatial resolution ∆x=0.25mm
were used to generate the electrical waves. In addition, APD restitution curve is quantified with
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the S1-S2 protocol. The left of the cable is paced at a basic cycle length of 1000ms with the S1
stimulus until steady-state is reached and is then perturbed by a stimulus (S2) after waiting a
variable-length interval. (3) In the 2D tissues, the 𝐼𝑠𝑡𝑖𝑚 amplitude is twice the diastolic threshold,
i.e., 52pA/pF. The spatial resolution ∆x is 0.04cm, and the temporal resolution ∆t is 0.02ms. The
spiral wave was initiated by applying a first stimulus (S1=2ms) along one side of the tissue to
generate a rectilinear wave propagating toward the other side. When the refractory tail of electrical
waves reaches the middle, a second stimulus (S2=5ms) will be given in the middle of the tissue,
paralleling to the first rectilinear wave covering only 3/4 of the length of the tissue [21].
Table 2-2 Numerical accuracy of APD and CV at different ∆x and ∆t.
∆t = 0.01 ms
∆x(cm)

APD (ms)

0.02

323.00

71.38

∆t = 0.02 ms
APD
CV (cm/s)
(ms)
322.98
69.89

0.025

322.96

69.44

322.94

68.10

0.03

322.94

67.43

322.92

66.26

0.035

322.94

65.31

322.92

64.31

0.04

322.94

63.06

322.92

62.23

CV (cm/s)

We measured the CVs at different spatial and time resolutions for four glycosylation conditions
on a cable of 600 cells. Note that Table 2-2 does not include the CVs and APDs for different
glycosylation conditions. This is because 𝐼𝑁𝑎 is the main contributor to excite a cardiac cell and
trigger electrical conduction. In this investigation, we assumed that only hERG channels have
altered glycosylation and all other channels (including 𝑁𝑎+ channel) remain unchanged. In the 1D
cable, the CVs are primarily controlled by the front of the waves (i.e., 𝐼𝑁𝑎 current). Hence, insilico experiments show that CVs are approximately the same for different glycosylation
conditions at the same ∆x and ∆t. However, when electrical waves propagate in the tissues, not
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only the front of the waves, but also the back of the waves (i.e., refractory period) could affect the
conduction. This will be shown later in the section of results of spiral waves.
Here, the APD and CV decrease slightly when ∆x increase from 0.02cm to 0.04cm at both time
steps. When ∆t increases from 0.01ms to 0.02ms, there is a slight decrease in both APD and CV.
These small variations are mainly due to the approximation errors in the numerical analysis. The
models of cardiac cell and tissue are solved with the use of Ode15s solver and explicit finite
difference methods. Computer models were implemented using Matlab R2010a and Simulink v7.5
software from MathWorks (Natick, MA, USA) in a Windows 7 (Microsoft, Redmond, WA, USA)
64-bit machine.
2.4

Results and Discussions

2.4.1 Glycosylation Modulation of hERG Channel
Table 2-3 Markov state transition rates under four glycosylation conditions.
Full glycosylation

Reduced Sialylation

Mannose-rich

N-Glycanase

𝛼0

0.0312·exp(0.0165V)

0.018633·exp(0.0234V)

0.0199·exp(0.0254V)

0.0173·exp(0.022V)

𝛽0

0.0993·exp(-0.0269V)

0.0413·exp(-0.03533V)

0.0469·exp(-0.0385V)

0.0364·exp(-0.0318V)

𝛼1

0.0036·exp(0.0221V)

0.0024·exp(0.0210V)

0.0025·exp(0.0225V)

0.0023·exp(0.0195V)

𝛽1

0.0003·exp(-0.0088V)

1.55E-4·exp(-0.0195V)

1.55E-4·exp(-0.0209V)

1.48E-4·exp(-0.0181V)

𝛼𝑖

0.0127·exp(-0.0343V)

0.0274·exp(-0.0357V)

0.0293·exp(-0.0393V)

0.0250·exp(-0.0320V)

𝛽𝑖

0.4916·exp(0.0065V)

0.4660·exp(0.0048V)

0.5771·exp(0.0063V)

0.3458·exp(0.0032V)

𝛼𝑖3

8.04E-5·exp(3.86E-7V)

1.53E-6·exp(6.34E-7V)

1.54E-6·exp(6.47E-7V)

1.53E-6·exp(6.2E-7V)

𝐾𝑓

0.0262

0.0296

0.0321

0.0272

𝐾𝑏

0.1478

0.2136

0.2297

0.1972

Markov model of hERG channels is optimally calibrated to reproduce the in-vitro data from the
whole-cell voltage clamp experiments. Note that the SSA and SSI curves were obtained using the
same pulse protocol from simulated currents as well as from in-vitro experiments (see Figure 2-3).
First, we performed the sensitivity analysis on the Markov model to identify transition rates that
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maximally impact the in-silico data for each pulse protocol. Second, a constrained nonlinear
optimization algorithm, i.e., trust-region-reflective [28], is employed to identify the parameters of
transition rates. The objective function is to find optimal parameter values that minimize the sum
of the least-square errors between in-silico and in-vivo data. Note that the parameter values from
Mazhari et al. [16] were used as initial guesses in the minimization procedure. A full list of the
parameters of transition rates under 4 glycosylation conditions is reported in Table 2-3.
Figure 2-3 shows the fitted SSA and SSI relationships of hERG under four glycosylation
conditions. Note that the SSA and SSI curves are shifted rightward (5~15mv) to more
hyperpolarized potentials. In other words, N-glycans limits hERG voltage-dependent activation
and inactivation by shifting the half-activation voltage of hERG to more depolarized potentials
(see Table 2-3 for parameter values). Thus, changes in glycosylation modulate the voltagedependent gating behaviors of hERG ion channels.
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Figure 2-3 The hERG channel gating and kinetics under four glycosylation conditions. (a) Steadystate activation (b) Steady-state inactivation. (In-vitro data as reported by us previously [26]: ■
Full Glycosylation ●Reduced Sialylation▲Mannose Rich▼N-Glycanase, In-silico data from the
Markov model: straight and dashed lines).
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2.4.2 Reduced Glycosylation Modifies 𝐼𝐾𝑟 and Shortens APD
The measured shifts in SSA and SSI with changes in glycosyaltion would likely modulate 𝐼𝐾𝑟
during the repolarization phases of the AP. Further, we integrate glycosylation-channel
interactions (see Figure 2-3 from the whole-cell patch clamp experiments) with the in-silico model
of cardiac cell to predict whether and how reduced glycosylation will impact the 𝐼𝐾𝑟 currents and
action potentials. As shown in Figure 2-4, the 𝐼𝐾𝑟 current is shifted leftward along the time axis
with earlier and higher current densities under 3 reduced glycosylation conditions (i.e., reduced
sialylation, mannose-rich, and N-Glycanase). When hERG channels recover from the inactivation
to the activated state, the repolarized cell will decrease the AP from the peak value to resting
potential. As shown in Figure 2-4, the N-Glycanase treated cell has a early peak in the 𝐼𝐾𝑟 current
along the time axis. This indicates the efflux of potassium current occurs earlier (i.e., repolarization)
in Phases 2 and 3 of AP. It may also be noted that mannose-rich and reduced sialylation treated
cells have similar 𝐼𝐾𝑟 spike shapes except the former has a higher peak in Figure 2-4. The larger
rightward shift in SSI curve measured for the mannose-rich conditions (See Figure 2-3 b) are likely
responsible for this higher peak. In other words, hERG channels under mannose-rich conditions
would recover from inactivation at more depolarized potentials during the AP, therefore the hERG
channel would be more active during the AP, causing an increased 𝐾 + efflux.
Figure 2-5 shows that reduced glycosylation shortens the action potential duration (APD), and
the N-Glycanse treated cell yields the shortest APD. When 𝐾 + efflux increases, the
transmembrane potential decreases quickly and the cell repolarizes to the resting potential more
quickly. Reduced glycosylation promotes an earlier/higher 𝐼𝐾𝑟 peak, thereby leading to a faster
repolarization and a shortened APD. (see Figure 2-5). In addition, we validated the results from
in-silico models by measuring hERG current in CHO cells treated with N-Glycanase and under
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conditions of full glycosylation. As shown in Figure 2-6, in-vitro 𝐼𝐾𝑟 currents [26] match the
simulated 𝐼𝐾𝑟 curves in major characteristics (e.g., leftward shifted and higher amplitude in the NGlycanase treated conditions), but with more random variations in the in-vitro data.
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Figure 2-4 Predicted rapid delayed rectifier K+ current (𝐼𝐾𝑟 ).
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Figure 2-5 Human ventricular action potential under four glycosylation conditions.
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Figure 2-6 Comparison between in-vitro and simulated 𝐼𝐾𝑟 currents.

2.4.3 Reduced Glycosylation Affects the APD Restitution in A Single Cell
We measured the APD restitution with the S1-S2 restitution protocol. The cell is paced at a
basic cycle length (BCL) with the S1 stimulus until steady-state is reached and is then perturbed
by a stimulus (S2) after waiting a variable-length interval. In our experiments, S1 stimulus is
applied for 30 cycles to reach the steady state. Also, two different BCLs, i.e., 1000ms and 2000ms
were used. Both S1 and S2 stimulus are 1ms duration and 38pA/pF amplitude.
Figure 2-7 a and b shows the APD90 restitution curves APDn+1 = f(DIn ) at the BCL of 1000ms
and 2000ms, respectively. Note that the BCL of 1000ms yields a similar shape of APD90 restitution
curve as the 2000ms. The APD increases with the DI, and the reduce glycosylated cell has smaller
APD90 than the fully glycosylated one. However, there is a negative slope (𝑑𝑓/𝑑(𝐷𝐼) =< 0) at
small DIs, i.e., 15ms~22ms (see Figure 2-7a) for the BCL of 1000ms. For the BCL of 1000ms, the
minimal DI is 74.56ms, 73.16ms, 73.75ms and 70.69ms respectively for full glycosylation,
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reduced sialylation, mannose rich and N-Glycanase. The minimal DI is calculated when the slope
of APD90 restitution curve reaches 1 (i.e., 𝑑𝑓/𝑑(𝐷𝐼) = 1). Note that the minimal DI interval in
the condition of full glycosylation is the largest. Similar results were obtained for the BCL of
2000ms. The minimal DI interval is slightly smaller, i.e., 71.89ms, 64.29ms, 68.23ms and 64.74ms
respectively for full glycosylation, reduced sialylation, mannose rich and N-Glycanase.
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Figure 2-7 Single-cell action potential duration (APD) restitution curves. The cell is stimulated
with the pacing rates of 1Hz (a) and 0.5Hz (b).
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Figure 2-8 Protocol and CV restitution of 1D cable. (a) The experimental protocol, (b) CV
restituion of 1D cable at Full Glycosylation, Reduced Sialylation, Mannose Rich and N-Glycanase.
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2.4.4 Conduction Velocity
We measured the conduction velocity (CV) restitutions on 1D cables composing of 1400 cells.
The S1-S2 protocol used is similar to the one in the APD restitution of 1D cable. As shown in
Figure 2-8, we varied the pacing period between S1 and S2 stimulus to investigate the impact on
the CVs. Note that the CVs increase when the pacing period increase, and tend to be the same for
four glycosylation conditions when the pacing period is > 650ms. However, when the pacing
period <650ms, the CVs for full glycosylation are smaller than others. This is because the
refractory period is larger for fully glycosylation condition. Also, when the pacing period is <
370ms, the CVs of reduced sialylation and mannose rich are smaller than the N-Glycanase. The
minimal pacing period (i.e., if smaller than this interval, electrical waves cannot be stimulated) is
350ms, 340ms, 342ms and 338ms respectively for full glycosylation, reduced sialylation, mannose
rich and N-Glycanase.
2.4.5 Reduced Glycosylation Affects 𝐼𝐾𝑟 Magnitudes, APDs at Different Pacing Rates, and APD
Restitution in A Cardiac Cable
Figure 2-9 shows the variations of 𝐼𝐾𝑟 currents (peak currents) of four glycosylation conditions
at different pacing rates in a linear cable of cardiac cells. In our experiments, 600 cardiac cells are
connected to form a cell cable. The first cell in the cable is stimulated. The 𝐼𝐾𝑟 for the 200th cell
are collected in the steady state. In order to make sure the stability, computer experimental results
are collected after the first cell is stimulated for at least 20 times. As shown in Figure 2-9, the 𝐼𝐾𝑟
magnitude decreases 30.98%, 26.08%, 17.37% and 32.73% when the pacing period increases from
400ms to 2000ms for full glycosylation, reduced sialylation, mannose rich and N-Glycanase,
respectively. However, the differences of 𝐼𝐾𝑟 magnitudes are bigger between four glycosylation
conditions for the larger pacing period, i.e., 1000ms-2000ms (see Figure 2-9).
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Figure 2-9 The variations of 𝐼𝐾𝑟 magnitudes in 1D cable. The peaks of 𝐼𝐾𝑟 currents are measured
with respect to different pacing periods under the conditions of Full Glycosylation, Reduced
Sialylation, Mannose Rich and N-Glycanase.

Figure 2-10 shows the variations of APDs of four glycosylation conditions, i.e., Full
Glycosylation, Reduced Sialylation, Mannose Rich and N-Glycanase, at different pacing rates in
a linear cable of 600 cells. Similarly to the experiments of 𝐼𝐾𝑟 currents, the first cell in the cable is
stimulated. The APDs for the 200th cell are collected in the steady state (i.e., after the first cell is
stimulated for at least 20 times). Modeling results shows that APD90 increases when the pacing
period increases from 400ms to 2000ms (see Figure 2-10). Note that APD90 differences decrease
among 3 reduced glycosylation conditions when the pacing period increases. However, if we
compare reduced glycosylation with full glycosylation, the effect to shorten the APD90 is the same
for different pacing periods (see Figure 2-10). It may also be noted that the APD90 differences
among 3 reduced glycosylation conditions vanish when the pacing periods is greater than 1500ms.

36

330

310
300

APD

90

(ms)

320

290
280

Full Glycosylation
Reduced Sialylation
Mannose Rich
N-Glycanase

270
260
500

1000
1500
Period (ms)

2000

Figure 2-10 The variations of APDs in 1D cable. APDs are measured at different pacing periods
under the conditions of Full Glycosylation, Reduced Sialylation, Mannose Rich and N-Glycanase.
We also measured APD restitution 𝐴𝑃𝐷𝑛+1 = 𝑓(𝐷𝐼𝑛 ) for a linear cable of 600 cells with the
S1-S2 restitution protocol (see details in Section 2.3, computer experiments). Note that the
experiments of APD restitution not only quantify the effects of glycosylation on the minimal
diastolic interval (DI), but also potentially indicate the stability of spiral waves. In other words,
the slope of APD restitution curve provides potential information on the alternans or breakups of
spiral waves [28]. In our experiment, S1 stimulus is applied in the first cell for 20 cycles at the
basic cycle length (BCL) of 1000ms to reach the steady state. The APD90 restitution curve for the
200th cell is collected. As shown in Figure 2-11, the APD increase with DI. The slope of APD
restitution curve are greater than or equal to 1 (i.e., 𝑑𝑓/𝑑(𝐷𝐼) ≥ 1 ) for four glycosylation
conditions. This indicates that reduced glycosylation does not increase the probability of spiral
wave breakups. In addition, the minimal DIs that elicit a propagating action potential are 99.02ms,
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99.44ms, 99.58ms and 99.40ms for full glycosylation, reduced sialylation, mannose rich and NGlycanase, respectively. Note that the minimal DI in tissues is often larger than a single cell
because of the effects of cell coupling and electrical conduction.
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Figure 2-11 The APD restitution curve of 1D cable.

2.4.6 Reduced Glycosylation Affects the AP Propagation in the Inhomogeneous Cable
Repolarization heterogeneity can potentially cause inhomegeneous electrical wavelength in
cardiac fibers. As depicted in Figure 2-12 a-c, we connected 600 inhomogeneous ventricular cells
with gap junctions in a linear cable. The first 300 cells are fully glycosylated and the next 300 cells
are under one of the following conditions: reduced sialylation (a), mannose-rich (b), or NGlycanase (c). The stimulus is initiated in the first cell, then adjacent cells are consecutively
excited until electrical waves are conducted to the end of the tissue. The abruptions in electrical
waves indicate the heterogeneity of APD between fully glycosylated cells and less glycosylated
cells. Such a repolarization heterogeneity may potentially increase the risks of cardiac arrythmia.
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The comparisons under those conditions are presented in Figure 2-12 d-f, which represent the
differences between the inhomogenous cables (see Figure 2-12 a-c) and a homogenous cable, i.e.,
fully glycosylated. The N-Glycanase treated cable is shown to have the most significant abruptions
in electrical wave conductions. Experimental results are consistent with predicted effects on
cardiac electrical signaling based on multi-scale modeling of hERG ion channel, cardiac cells and
tissues (i.e., cable). Reduced glycosylation modulates the gating of hERG channels, shortens the
APD of cardiac cell, and affects the AP repolarization in cardiac cable. If periodic stimuli are
applied, reduced glycosylation can also potentially vary electrical propagation in a linear cable of
cells.
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Figure 2-12 AP propagation along a 1D inhomogeneous cable with 600 cells.The first 300 cells
are fully glycosylated and the second 300 cells are under the reduced glycosylation conditions: (a)
Reduced Sialylation, (b) Mannose Rich, and (c) N-Glycanase. The comparison plots (d-f) represent
the differences between (a-c) vs. a Fully Glycosylated cable.
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2.4.7 Reduced Glycosylation Affects Electrical Conduction in 2D Cardiac Tissues
Little is known about how reduced glycosylation affects electrical conduction in 2D cardiac
tissues [29]. Most previous work focused on glycosylation modulation effects at the levels of ion
channels (e.g., sodium and potassium channels) and cells. Note that electrical conduction may
produce either non-spiral or spiral waves in 2D tissues.
Non-spiral waves often represent normal cardiac electrical conductions. The stimulus (i.e., 52
pA/pF) is applied along the entire left edge of the tissue, and electrical waves propagate toward
the right side (see Figure 2-13a). Because there are no potential gradients in the perpendicular
direction, this type of electrical propagation in 2D tissues is similar to the 1D cable.
However, spiral waves are modeling reentrant cardiac arrhythmias. The reentry on 2D tissue
was generated using the pulse protocols that are introduced in Section 2.3 – Computer Experiments.
As shown in Figure 2-13, three virtual electrodes were placed at the locations as follows:
E1 (60, 60,60), E2 (60, 600,60) , E3 (600, 330,60) . The 3-lead ECG signals were derived to
quantify the effects of reduced glycosylation on electrical conductions.
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Figure 2-13 The propagation of rectilinear waves and spiral waves in 2D cardiac tissues. Three
virtual electrodes are placed at 𝐸1 , 𝐸2 and 𝐸3 . The 3-lead ECGs are derived based on the potential
differences between two electrodes.
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First, we simulated the propagation of normal electrical waves (i.e., rectilinear waves in Figure
2-13a) in fully glycosylated and N-Glycanase treated ventricular tissues, assuming that only hERG
channel gating is impacted by changes in glycosylation. As shown in Figure 2-14a, lead I, II, III
ECG signals capture electrical conduction along 3 different directions in 2D tissues. It may be
noted that the wavelength of ECG signals of N-Glycanase treated tissues is shorter than fully
glycosylated tissue. Because ECG signals are derived from a piece of ventricular tissue instead of
a 3D heart, it is difficult to obtain T wave. However, 3-lead ECG signals indicate that reduced
glycosylation influences the electrical propagation on the 2D tissue. Further, the waveforms of
ECG signals demonstrate that reduced glycosylation will shorten the wavelength in ECG signals.
The in-silico prediction results show that reduced glycosylation can potentially be used to shorten
the QT interval, thereby controlling the LQTS.
Second, spiral waves were simulated in the fully glycosylated and N-Glycanase treated
ventricular tissues to investigate how reduced glycoslyation will impact the progression of
reentrant cardiac arrhythmias. Note that spiral wave simulations roughly correlate with
monomorphic ventricular tachycardia. Two spiral waves were rotating for at least 8s to reach the
steady state. As shown in Figure 2-15, there are distinct differences in the wave lengths between
full glycosylation and N-Glycanase treated. The measurements show that N-Glycanase treated
tissue yields a smaller width of wave (L2 = 5.64 cm) than the fully glycosylated one (L1 = 6 cm).
This indicates that the vulnerability to arrhythmia is different for reduced hERG channel
glycosylation, because the wave length impacts not only the propagation of electrical waves in
space but also the rotating cycle of the vortex.
Furthermore, we derived the 3-lead ECG to characterize how N-Glycanase treatment of hERG
channels impacts the propagation of spiral waves. Figure 2-13b depicts the locations of 3
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electrodes for deriving the ECG. As shown in Figure 2-14b, the waveforms of ECG signals are
distinctly different from the ones in rectilinear waves, because spiral waves represent and model
cardiac arrhythmias. In addition, N-Glycanase treated tissue is predicted to yield a shorter RR
interval than fully glycosylated tissue. In other words, N-Glycanase treated tissue takes less time
to fulfill a single cardiac cycle than full glycosylation, when stimulated with the same protocol,
assuming only hERG channel gating is impacted by N-Glycanase treatment. Figure 2-14b shows
that N-Glycanase yields the ECG cycle of 0.207s, which is shorter than 0.22s in full glycosylation.
Because of the prolonged T wave in LQTS, depolarization often occurs during the late
repolarization phase of the previous ECG cycle (R on T phenomenon) [11]. Therefore, NGlycanase can potentially prevent a premature depolarization by shortening the ECG cycle. This
can potentially reduce the risk of LQTS and spiral wave breakups (i.e., Ventricular Tachycardia is
less likely transfer into Ventricular Fibrillation) [30].
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Figure 2-14 Derived Lead I, II, III ECG signals from the propagation of rectilinear waves and
spiral waves in 2D cardiac tissues. (Solid black line: Fully Glycosylation. Red dash line: NGlycanase treated.)
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Figure 2-15 Spiral waves in fully glycosylated & N-Glycanase treated cardiac tissues.

2.4.8 State Occupancy of hERG Channels
Figure 2-16 shows how reduced glycosylation impacts the state occupancy in the Markov model
of hERG channels. Note that fully glycosylated channel transfer out of C1 to O and I faster than
reduce glycosylated channels. At the early stage of AP (phase 0-2), hERG channel mostly stays in
I and C, and switches to O in the rapid repolarization phase (Figure 2-16 c-d). Figure 20 d shows
the state occupancies at 287ms. Noted that fully glycosylated channels are out of C and stay in I,
while reduce glycosylated channels has already began to enter the O state. At 300ms (Figure 2-16
e), fully glycosylated channels transfer from I to O, but reduce glycosylated channels enter more
and more into the O state and begin to go back to C. The state occupancy diagram in different
glycosylation conditions shows the glycosylation-modulated variations of 𝐼𝐾𝑟 and AP.
2.5

Conclusions

In the pharmaceutical industry, in-vitro and in-vivo experiments are widely used to characterize
and quantify the drug effects on biological systems. However, there are often many practical and
ethical limitations in physical experiments of animal or human subjects. Also, it is very expensive
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and difficult to comprehensively conduct physical experiments across biological scales, e.g., from
ion channels to cells to tissues. In-silico models allow one to overcome these limitations, discover
gaps in the in-vivo data, derive new hypotheses and/or suggest new experimental designs.

Figure 2-16 Markov state occupancy under the conditions of full glycosylation, reduced sialylation,
mannose-rich and N-Glycanase.

Although computer models have long been intertwined with physical experiments in cardiac
research, no approach to date has integrated the understanding of cardiac function in variable levels
of glycosylation across the physical scales of increasing complexity, from molecules to cells to
tissues. Note that cardiac ion channels are heavily glycosylated, and slight changes in the glycan
structure can possibly impact the gating behaviors of ion channels. This study made one of the first
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attempts to integrate glycosylation-channel data from in-vitro experiments with in-silico models
to investigate how aberrant glycosylation modulates hERG ion channels and, as a result, cardiac
electrical signaling across different organization levels, from molecule to cell to tissues.
Currently, little data is available about how reduced glycosylation will impact the gating of
hERG channels [26]. In this present investigation, it is shown that reduced glycosylation, i.e.,
reduced sialylation, mannose-rich and N-Glycanase, shifts the steady-state activation and
inactivation of hERG channels towards more positive potentials. These measured changes were
integrated with in-silico models to predict glycosylation modulation dynamics on cardiac cells and
tissues. The results of computer experiments show that reduced glycosylation increases the 𝐼𝐾𝑟
magnitudes and shortens the APD. These glycosylation-induced changes are consistent over a
range of pacing rates from 0.5 Hz to 2Hz, but they are less pronounced for faster rates. Also, the
APD restitution indicates that reduced glycosylation does not increase the probability of spiral
wave breakups. Further, the abruptions in inhomogeneous cable experiments show that reduced
glycosylation affects the AP repolarization and shortens the wavelength in 1D cable. It may be
noted that N-Glycanase has the most significant effect on cardiac repolarization and electrical
propagations. Moreover, 3-lead ECGs derived from rectilinear waves and spiral waves in 2D
tissues demonstrate that reduced hERG channel glycosylation narrows the width of waves,
shortens the QT interval, and speeds up the reentry.
Because QT intervals are closely related to ventricular repolarization and hERG ion channel
gating, a better understanding of glycosylation modulation dynamics in hERG ion channels can
suggest a possible new mechanism to control QT intervals in ECG signals. As a result, new
"rescue" therapies can be developed by imposing a glycan-dependent change in channel function
that counterbalances the dysfunction due to diseases such as long QT syndrome. Our future studies
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will be dedicated to a continued understanding of how regulated and aberrant glycosylation
impacts cardiac function using in-vitro and in-vivo experiments as well as in-silico simulations as
tools to test this novel mechanism for the control of cardiac electrical signaling.
2.6
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Chapter 3 Statistical Metamodeling and Sequential Design of Computer Experiments to
Model Glyco-altered Gating of Sodium Channels in Cardiac Myocytes
Glycan structures account for up to 35% of the mass of cardiac sodium (𝑁𝑎𝑣 ) channels. To
question whether and how reduced sialylation affects 𝑁𝑎𝑣 activity and cardiac electrical signaling,
we conducted a series of in-vitro experiments. Although aberrant electrical signaling is observed
in reduced sialylation, realizing a better understanding of mechanistic details of pathological
variations in 𝐼𝑁𝑎 and AP is difficult without performing in-silico studies. However, computer
model of 𝑁𝑎𝑣 channels and cardiac myocytes involves greater levels of complexity, e.g., highdimensional parameter space, nonlinear and non-convex equations. Traditional linear and
nonlinear optimization methods have encountered many difficulties for model calibration. This
study presents a new statistical metamodeling approach for efficient computer experiments and
optimization of 𝑁𝑎𝑣 models. First, we utilize a fractional factorial design to identify control
variables from the large set of model parameters, thereby reducing the dimensionality of
parametric space. Further, we develop the Gaussian Process (GP) model as a surrogate of
expensive and time-consuming computer models and then identify the next best design point that
yields the maximal probability of improvement. This process iterates until convergence, and the
performance is evaluated and validated with real-world experimental data. Experimental results
show the proposed algorithm achieves superior performance in modeling glycosylated and
controlled kinetics of 𝑁𝑎𝑣 channels. As a result, in-silico models provide a better understanding of
glycol-altered mechanistic details in state transitions and distributions of 𝑁𝑎𝑣 channels. Notably,
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ST3Gal4-/- myocytes are shown to have higher probabilities accumulated in intermediate
inactivation during the repolarization and yield a shorter refractory period than WTs. The proposed
approach of statistical design of computer experiments is generally extensible to many other
disciplines that involve large-scale and computationally expensive models.
3.1

Introduction

Action potential (AP), the net change of transmembrane potential in a cardiac myocyte during
a contraction cycle, is produced by the orchestrated function of ion channels. A slight change in
ion channel activity may affect the AP waveform and electrical conduction, thereby potentially
leading to severe cardiac disorders. Voltage-gated sodium (Nav ) channel activity is responsible for
the excitation of cells and contributes to electrical conduction in tissues [1, 2]. It was shown that
Nav channels can be extensively post-translationally modified by protein glycosylation through
isoform-specific mechanisms [3-8]. Typically, glycosylation-dependent gating effects were
imposed on ion channels primarily by the terminal residue attached to N- and O-glycans, sialic
acid [3-8]. Montpetit et al. showed that cardiac glycome (i.e., the complete set of glycan structures
produced in the heart) varies between atria and ventricles, and changes differentially during
development of each cardiac chamber. In addition, regulated expression of a single glycogene was
shown to modulate AP waveforms and gating of less sialylated Nav consistently [9].
Growing evidence suggests that reduced glycosylation has dramatic effects on ion channels and
cardiac electrical signaling. There is a set of >40 distinct forms of inherited human diseases of
reduced glycosylation known as Congenital Disorders of Glycosylation (CDG) caused, typically,
by a mutation or deficiency in a glycogene that results in a relatively modest reduction in
glycoprotein glycosylation [1-14]. While the mechanism(s) is not yet understood, recently reported
prevalence of cardiac involvement prompted experts to suggest screening for cardiac dysfunction
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in all CDG patients and for CDG in all young patients suffering from cardiomyopathy of unknown
etiology [15].
In order to question whether and how reduced glycosylation affects 𝑁𝑎𝑣 activity and cardiac
electrical signaling, we conducted a series of electrophysiological experiments to measure and
characterize sodium currents (𝐼𝑁𝑎 ) and action potentials (AP). The experiments showed that
ventricular 𝑁𝑎𝑣 from the sialyltransferase beta-galactoside alpha-2,3-sialyltransferase 4 (ST3Gal4)
deficient mice (ST3Gal4-/-) inactivated more slowly and recovered from fast inactivation more
rapidly than wild type (WT) controls, and ST3Gal4-/- cell showed a shortened myocytes refractory
period. Although we observed aberrant electrical signaling in ST3Gal4-/- ventricular myocytes and
across the ST3Gal4-/- ventricle, understanding mechanistic details of pathological variations in INa
and AP is very difficult without performing in-silico studies. Experiments can measure ionic
currents 𝐼𝑁𝑎 and AP with voltage and current clamp protocols, but preclude us from determining
directly the change in transitions among molecular states (e.g., open, close, intermediate inactivated,
and fast inactivated states) and their systematic contributions to AP variations. There is an urgent
need to integrate computer models with experimental data to model the variations of state transitions
under conditions of reduced sialylation, and the resulting changes in ionic currents and AP.
In this present study, we propose to couple in-silico studies with the wealth of data from our
electrophysiological experiments to model, mechanistically, how reduced sialylation that occurs
in the ST3Gal4−/− heart affects 𝑁𝑎𝑣 channel activity and electrical signaling in the adult mouse
ventricle. Indeed, computer models not only overcome practical and ethical limitations in physical
experiments but also provide predictive insights into the underlying mechanisms.
Computer models of Nav channels involve greater levels of complexity, e.g., the high
dimensionality of parameter space, nonlinear and non-convex characteristics. Hodgkin and Huxley
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formulated the first model of myocyte AP in 1952 using a set of nonlinear and ordinary differential
equations, including the submodels of potassium, sodium and leak channels. However, HodgkinHuxley model is not adequate to capture detailed gating mechanisms of 𝑁𝑎𝑣 channels. Further,
Clancy and Rudy developed a 9-state Markov model for INa with three closed states (C1, C2, C3),
one fast inactivation (IF), one open state (O), two intermediate inactivated states (I1, I2) and two
closed-inactivation states (IC2, IC3) [18]. The dynamic transitions among Markov states involve
a large set of interacting nonlinear differential equations, and thus lead to highly nonlinear and
non-convex characteristics in the model.
In order to model glyco-altered 𝐼𝑁𝑎 , there are a total of 25 calibration parameters that need to
be estimated (also see Table 3-1). This gives rise to the issue of “curse of dimensionality” for
model calibration because we would need 225 (approximately 33.5 million) design points to run
full-factorial experiments that fill up the corner points of a 25-dimensional hypercube. In addition,
we will need to follow standard pulse protocols used in electrophysiological experiments (i.e.,
steady state activation, steady state inactivation and recovery from fast inactivation) to design
computer experiments for the minimization of model discrepancy from real-world experimental
data. In other words, this is a multi-objective optimization problem instead of a single objective
function. As such, the process of model calibration is very computationally expensive, due to the
running of complex Markov model in the high-dimensional design space. It should be noted that
traditional linear and nonlinear optimization methods (e.g., interior point algorithm, trust-region
reflective algorithm, Levenberg-Marquardt algorithm and genetic algorithm) have encountered
many difficulties, even infeasible, for 𝐼𝑁𝑎 model calibration and computer experiments.
This study presents a new statistical metamodeling approach for efficient computer experiments
and optimization of 𝑁𝑎𝑣 channel models, so as to describe glyco-altered 𝑁𝑎𝑣 gating kinetics using
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a model for reduced Nav channel sialylation as an experimental model system in the ST3Gal4−/−
heart. The organization of this study is as follows: Section 3.2 presents the research methodology,
including screening design, space-filling design, statistical metamodel and the maximal probability
of improvement; section 3.3 introduces the materials and experimental protocols; Section 3.4
presents experimental results; Section 3.5 includes the conclusions arising out of this investigation.
3.2

Research Methodology

It is well known that cardiac models involve a large set of nonlinear differential equations with
a high-dimensional space of model parameters. As a result, nonlinear and non-convex
characteristics pose significant challenges for traditional optimization methods to achieve optimal
solutions. In addition, solving nonlinear differential equations are often heavily computationallyexpensive when a large number of experimental runs are needed. It is impractical to seek an
optimal solution through the exhaustive search (or full-factorial experiments) in the highdimensional design space. Hence, there is an urgent need to minimize the number of runs (i.e.,
reduce the computational cost and time) while calibrating computer models. However, few, if any,
previous studies have focused on the statistical design of experiments for model calibration in the
field of cardiac simulation and modeling. The present investigation is the first of its kind to
integrate statistical metamodeling with sequential design of experiments for efficient and effective
calibration of cardiac models.
As shown in Figure 3-1, this present investigation is embodied by three core components
focusing on the development of statistical metamodels for efficient and effective calibration of
cardiac models. (1) The first component is aimed at the screening of model parameters so as to
identify control variables that are sensitive to response functions. Notably, this present
investigation includes three different response functions in the computer model of Nav channels
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(i.e., steady state activation, steady state inactivation and recovery from fast inactivation). As such,
we designed the fractional factorial experiments to identify control variables that are sensitive to
one response function but not others. This first component will screen important variables and
reduce the dimension of design space, thereby improving the effectiveness and efficiency of
statistical metamodeling. (2) The second component will develop statistical metamodels to predict
the response functions in the control variable space based on a small sample of computed responses
from computer models. The statistical metamodels will serve as the surrogates of expensive and
time-consuming computer models. (3) The third component aims to develop an expected
improvement algorithm, extended from Jones et al [19], to calculate the responses of statistical
metamodels based on a space-filling design and then select the next best point according to the
criterion of maximal probability of improvement for running an additional experiment on
computer models. Further, this process will continue selecting the next best point and updating the
statistical metamodel until the convergence criterion is satisfied. All three components are
eventually integrated together in the framework of sequential design of computer experiments to
make the calibration of computer models of complex cardiac systems more effective and efficient.
The details of this new method are described below.
3.2.1 Screening Design
In order to avoid the “curse-of-dimensionality”, it is critical to study the effects of model
parameters for identifying control variables that are sensitive to model discrepancy instead of other
noise. In this investigation, the computer model includes output variables ỹ and the P-dimensional
parameters 𝒙 (i.e., the large set of covariates with potential effects on outputs) as follows:
Computer model: ỹ = 𝑓(𝑡, 𝒙, 𝑉)
Model parameters: 𝒙|𝑃 = (𝑥1 , 𝑥2 , … , 𝑥𝑃 )
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Control variables: 𝒙|𝑝 = (𝑥1 , 𝑥2 , … , 𝑥𝑝 )
Real experimental data: y
Model discrepancy: 𝛿 = |𝑦 − 𝑦̃|
The screening design is aimed at identifying a low-dimensional set of important control
variables (𝒙|𝑝, 𝑝 << 𝑃) from the high-dimensional set of potential model parameters (𝒙|𝑃) so as
to facilitate the process of statistical metamodeling. It is not uncommon that the “one-factor-at-atime (OFAT)” approach is used to investigate each parameter by itself, ignoring the other
parameters. The recommendation is made only based on how the change of a single parameter ∆𝑥
impacts the model discrepancy 𝛿. Although this is computationally efficient, this OFAT approach
cannot estimate the joint effects of parameters and can also miss important factors [20].

Computer Model
Costly
Maximize the Prob. of
Improvement

Initial Step

Iterative
Update
Screening Design
Fractional Factorial Design
Identify Control Variables
Space-Filling Design

Statistical Metamodeling
Cheap

Figure 3-1 Flow chart of the proposed research methodology.
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Hence, we adopted the fractional factorial design for the sensitivity analysis of parametric
effects on response functions. In this study, there is a set of 25 parameters that have potential
effects on the model discrepancy 𝛿 of 𝑁𝑎+ ion channels. If each parameter varies at two levels (+1
and -1), a full factorial design will require 225 = 33554432 runs, which is computationally
expensive and time consuming. Because some higher-order interactions are likely to be negligible
based on the effect hierarchy principle, we used a 1024-run 225−15
fractional factorial design. It
𝑉
should be noted that the resolution 𝑉 ensures that the main effects are strongly clear and the twofactor interactions are clear. If we denote the 25 parameters by letters ‘a’-‘y’, the design generators
derived from the Franklin-Bailey algorithm [21] are:
𝑘 = 𝑎𝑏𝑐𝑑𝑒𝑓𝑔ℎ𝑖𝑗; 𝑙 = 𝑑𝑒𝑓𝑔ℎ𝑖𝑗; 𝑚 = 𝑏𝑐𝑓𝑔ℎ𝑖𝑗;
𝑛 = 𝑎𝑐𝑒𝑔ℎ𝑖𝑗; 𝑜 = 𝑏𝑑𝑔ℎ𝑖𝑗; 𝑝 = 𝑐𝑒𝑓ℎ𝑖𝑗; 𝑞 = 𝑎𝑑𝑓ℎ𝑖𝑗;
𝑟 = 𝑎𝑏𝑒ℎ𝑖𝑗; 𝑠 = 𝑎𝑏𝑐𝑑ℎ𝑖𝑗; 𝑡 = 𝑎𝑏𝑒𝑓𝑔𝑖𝑗; 𝑢 = 𝑎𝑐𝑓𝑔𝑖𝑗;
𝑣 = 𝑐𝑑𝑒𝑔𝑖𝑗; 𝑤 = 𝑏𝑐𝑑𝑒𝑓𝑖𝑗; 𝑥 = 𝑏𝑒𝑓𝑔ℎ𝑗; 𝑦 = 𝑎𝑓𝑔ℎ𝑗
After obtaining computed responses from the 1024-run experiments on computer models,
factorial effects of parameters are estimated by the linear model as:
𝑃

𝛿 = 𝛽0 + ∑ 𝛽𝑖 𝑥𝑖 + 𝜀
𝑖=1

where 𝑖 = 1, … , 𝑃 is the number of considered parameters. Notably, the least squares estimate β̂i
is half of the factorial effect 𝑥𝑖 , i.e.
𝛽̂𝑖 =

1
(𝑦̅(𝑥𝑖 = 1) − 𝑦̅(𝑥𝑖 = −1))
1 − (−1)
=

1
(𝑦̅(𝑥𝑖 = 1) − 𝑦̅(𝑥𝑖 = −1))
2

As such, factorial effects are obtained by doubling the regression coefficients β̂i ′𝑠. Further, we
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used a graphical method, namely half-normal probability plot, to test the significance of factorial
effects. The fundamental idea is to use the normal curve as the reference distribution against which
the significance of effects is tested [22]. Under the null hypothesis of no significant effect, factorial
effects are approximately normally-distributed random noises, i.e., 𝛽̂𝑖 ~𝑁(0, 𝜎 2 ). As a result, any
effect whose point falls off the straight line in the half-normal probability plot is declared
significant. The half-normal probability plot is composed of points, i.e.,
[𝛷−1 (0.5 +

0.5[𝑖 − 0.5]
) , |𝛽̂(𝑖) | ] , 𝑖 = 1,2, ⋯ 𝑃
𝑃

where 𝛷 is the cumulative distribution function (CDF) of a standard normal random variable. The
absolute values of factorial effects are ordered as |β̂(1) | ≤ ⋯ ≤ |β̂(P) |, and then plotted against the
coordinates based on the half-normal distribution. In the half-normal probability plot, all the
significant effects will fall above the straight line of small factorial effects and appear in the upper
right corner of the plot. To this end, the initial step of variable screening identifies a reduced set
of control variables (𝒙|𝑝, 𝑝 << 𝑃) that will be used to construct statistical metamodels in the
following section 3.2.2 and 3.2.3.
3.2.2 Space-Filling Design
The next step is to select inputs 𝑿 = (𝒙1 , … , 𝒙𝑛 ), 𝑛 × 𝑝 dimension, at which to calculate the
responses of computer models. Space-filling design is commonly used in computer experiments
when prediction accuracy is a primary interest. In this present investigation, we proposed the
maximin distance design of Latin Hypercube (LH) Sampling to evenly spread the values of the
inputs in the experimental region.
In order to obtain a 𝑛 × 𝑝 LH sample 𝑿 = (𝒙𝟏 , 𝒙𝟐 , … , 𝒙𝒏 ) in the 𝑝 dimensional experimental
regions [0,1]𝑝 , each dimension [0,1] is first divided into 𝑛 equally spaced intervals [0,1/
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𝑛), … , [(𝑛 − 1)/𝑛, 1]. All p-dimensional Cartesian products of these intervals provide the 𝑛𝑝 cells
of equal size. Then, an 𝑛 × 𝑝 matrix 𝚷 = (Π𝑖𝑗 ) is generated so that its columns are random
permutations of {1,2, … , 𝑛} . The LH sample 𝑥𝑖𝑗 , 𝑖 = 1, … , 𝑛; 𝑗 = 1, … , 𝑝 is obtained from the
matrix 𝚷 as follows:
𝑥𝑖𝑗 =

Π𝑖𝑗 − 0.5
, 𝑖 = 1, … , 𝑛; 𝑗 = 1, … , 𝑝
𝑛

The LH sampling evenly distributes the design points when projecting onto the domain of each
input variable in the experimental region. Further, we used the maximin distance criterion to
measure the spread of design points in the experimental region. In other words, any pair of design
points should not be “too” close together. In this present investigation, the distance measure
between two design points 𝒙𝑖 and 𝒙𝑗 is defined as
𝑑𝑖𝑗 = ‖𝒙𝑖 − 𝒙𝑗 ‖
where ‖∙‖ denotes the Euclidean norm. The maximin distance design aims to maximize the
minimal distance between any two points in the design space, and thereby guarantee that design
points are spread over the experimental region [23]:
max𝐗∈[0,1]𝑑 min𝑖≠𝑗 𝑑𝑖𝑗
Figure 3-2 shows an illustration of maximin distance design in the 2-dimensional design space
[0,1]2 . Notably, the design in Figure 3-2 (a) has a smaller minimal distance between two design
points than Figure 3-2 (b). As such, design points in Figure 3-2 (b) are distributed more evenly. In
this present study, the domain of each control variable has a different range, and therefore design
points in the 𝑝 dimensional experimental regions [0,1]𝑝 are rescaled to their corresponding
domains. In addition, the LH sampling is repeated several times and then we select the one
maximizing the minimal distance between points.
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(a)

(b)

Figure 3-2 Maxmin Latin hypercube design.
3.2.3 Statistical Metamodeling
In this section, we will approximate the discrepancy between computer model and
electrophysiological data using the easy-to-evaluate statistical metamodels. This is done in two
steps. First, we will run the computer model to compute the responses at some settings of control
variables using the maximin Latin Hypercube Design (LHD). Then, we will fit statistical models
to capture the relationships between control variables and model discrepancy, which can be used
as an approximation model to minimize the discrepancy between computer model and
electrophysiological data. Notably, the prediction accuracy depends on the general tendency as
well as the uncertainty of statistical metamodels in modeling the response surface. Although the
metamodeling approach has been widely used in engineering [23, 24], we have not seen its
applications in the cardiovascular domain. In addition, functional responses, pulse protocols and
cardiac constraints call for the new development of statistical metamodeling methods that are wellsuited for cardiovascular studies.
In this present study, we adopted the Gaussian Process (GP) modeling approach to develop the
statistical metamodels. It is worth mentioning that GP model provides both mean and variance for
the estimations of complex response surfaces, which facilitates the subsequent prediction and
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uncertainty analysis of complex systems. Most of previous studies focused on the use of GP model
for calibrating computer models in the engineering domain, e.g., Kennedy and O’Hagan [25], Qian
and Wu [26], and Chang and Joseph [27]. However, calibrating cardiac models is not a
straightforward application of aforementioned works, due to nonlinear/non-convex characteristics
of models and different types of function responses (e.g., ion-channel currents and action
potentials). Cardiac models need to be calibrated with specific considerations of the kinetics and
physical properties of ion channels, cells, tissues, and the heart. This present investigation made
an attempt to bridge the gaps in statistical metamodeling between engineering and cardiac domains.
As aforementioned in Section 3.2.2, let ỹ be the model output and 𝑓(𝑡, 𝒙, 𝑉) be the computer
model, where 𝒙 = (𝑥1 , 𝑥2 , … , 𝑥𝑝 ) is a 𝑝-dimensional vector of control variables (or calibration
parameters). Let (𝒙𝟏 , 𝑦1 ), … , (𝒙𝒏 , 𝑦𝑛 ) be the real data obtained from electrophysiological
experiments. The output of such data usually contains some errors due to the variations in the
unobserved variables and measurement error. Therefore, we can write down the statistical model
as:
𝑧𝑖 = |𝑦𝑖 − 𝑓(𝑡, 𝒙𝒊 , 𝑉)| = 𝛿(𝒙𝒊 ) + 𝜖𝑖 , for 𝑖 = 1, … , 𝑛
where 𝜖𝑖 ~𝑖𝑖𝑑 𝑁(0, 𝜎𝑛2 ), and the bias term 𝛿(𝑥) is modeled as a Gaussian process [28-31] specified
by the mean function 𝑚(𝒙) and covariance function 𝑘(𝒙, 𝒙′ ), i.e.,
𝛿(𝒙)~𝐺𝑃(𝑚(𝒙), 𝑘(𝒙, 𝒙′ ))
𝑚(𝒙) = 𝔼[𝛿(𝒙)]
𝑘(𝒙, 𝒙′ ) = 𝔼[(𝛿(𝒙) − 𝑚(𝒙))(𝛿(𝒙′) − 𝑚(𝒙′))]
The GP is defined as a collection of random variables, any finite set of which follows a joint
Gaussian distribution. The GP is treated as a functional prior on the bias function [28-30]. Here,
the covariance function specifies the covariance between pairs of random variables:
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1
𝑘(𝒙, 𝒙′ ) = 𝜎𝑓2 exp (− (𝒙 − 𝒙′ )𝑇 𝑴(𝒙 − 𝒙′ ))
2
where 𝜎𝑓2 is the signal variance and 𝑴 = diag(𝑙)−2 with the length-scale vector 𝑙. Note that the
𝛿(𝒙) and 𝛿(𝒙′ ) should be similar if 𝒙 and 𝒙′ are sufficiently close in the design space, therefore,
the length scale 𝑙 defines the separation between different dimensions of input variables. For a new
design point 𝒙∗ , the computed bias 𝒁 from 𝑿 = (𝒙1 , … , 𝒙𝑛 ), and the predicted 𝛿(𝒙∗ ) have a joint
prior distribution with zero mean:
𝒁
𝐾(𝑿, 𝑿) + 𝜎𝑛2 𝑰
[ ] ~𝑁(0, [
𝛿∗
𝐾(𝒙∗ , 𝑿)

𝐾(𝑿, 𝒙∗ )
]
𝐾(𝒙∗ , 𝒙∗ )

In order to obtain the posterior distribution, this joint prior distribution is restricted to include only
those functions that agree with the computed observations from the space-filling design. Hence,
the posterior distribution of 𝛿∗ is:
𝑝(𝛿∗ |𝑿, 𝒁, 𝒙∗ )~𝒩(𝛿∗̅ , cov(𝛿∗ ))
𝛿∗̅ = 𝔼(𝛿∗ |𝑿, 𝒁, 𝒙∗ ) = 𝐾(𝒙∗ , 𝑿)[𝐾(𝑿, 𝑿) + 𝜎𝑛2 𝑰]−1 𝒁
cov(𝛿∗ ) = 𝐾(𝒙∗ , 𝒙∗ ) − 𝐾(𝒙∗ , 𝑿)[𝐾(𝑿, 𝑿) + 𝜎𝑛2 𝑰]−1 𝐾(𝑿, 𝒙∗ )
However, the hyper-parameters 𝜽 = {𝑴, 𝜎𝑓 , 𝜎𝑛 } need to be optimally chosen in order to yield
the best GP model for predicting the point with the maximal probability of improvement to reduce
the model discrepancy. These hyper-parameters can be learned by maximizing the log marginal
likelihood, i.e.,
𝜽𝐨𝐩𝐭𝐢𝐦𝐚𝐥 = argmax𝜽 {log 𝑝(𝒁|𝑿, 𝜽)}
1
1
𝑛
log 𝑝(𝒁|𝑿, 𝜽) = − log|𝐾 + 𝜎𝑛2 𝑰| − 𝒁𝑇 [𝐾 + 𝜎𝑛2 𝑰]−1 𝒁 − log2𝜋
2
2
2
As such, the GP is optimally trained with the real experimental data and computed responses
from the computer model based on the space-filling design. Figure 3-3 shows an example of GP
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model for one-dimensional curve fitting, where blue dots are observed data, and black line shows
the predictions from the GP model. The dash line indicates the prediction variances.

Figure 3-3 An illustration of Gaussian Process fitting of one-dimensional data.

3.2.4 Maximizing the Probability of Improvement
The statistical metamodel provides an approximate model of the functional relationship
between model discrepancy 𝑧 = |𝑦 − 𝑓(𝑡, 𝒙, 𝑉)| and control variables 𝒙. At any specific point 𝒙∗
in the experimental region, the GP model predicts our uncertainty about the model discrepancy as
the realization of a random variable 𝛿∗ with mean 𝛿∗̅ (𝒙∗ ) and standard error 𝑠(𝛿∗ |𝒙∗ ) (see Figure
3-4). However, this approximation is based on the initial set of design points 𝑿 = (𝒙1 , … , 𝒙𝑛 )
from the space-filling design. Hence, we introduced an auxiliary function of the probability of
improvement, extended from Jones et al [19], to identify an additional design point where the
probability to minimize model discrepancy beyond the target 𝑇 is the highest (see Figure 3-4):
𝑇 − 𝛿∗̅ (𝒙∗ )
ProbI = Φ (
)
𝑠(𝛿∗ |𝒙∗ )
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where Φ(∙) is the Normal CDF function. The target value is defined as 𝑇 = 𝛿min − 0.25|𝛿min | so
as to yield an improvement of at least 25%. Therefore, the objective to minimize the model
discrepancy is analogous to iteratively search the next best point 𝒙∗ that maximizes the probability
of improvement. In each iteration, we will compute the response and discrepancy of computer
model at this additional best design point 𝒙∗ , and then update the statistical metamodel to search
for the next best one.
2
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Figure 3-4 An illustration to estimate the probability at a given point to minimize model
discrepancy beyond the target T.

It is worth mentioning that if we sample densely around the current best point, the uncertainty
(i.e., standard error 𝑠(𝛿∗ )) in this region becomes small. As such, the quantity (𝑇 − 𝛿∗̅ )⁄𝑠(𝛿∗ ) is
highly negative because 𝑇 is often less than 𝛿∗̅ . This leads to small probability of improvement
around the current best point, thereby driving the algorithm to move to some points where the
uncertainty is higher. Therefore, the point that has maximal probability could improve the
metamodel most. This process will iterate until the convergence criterion is satisfied.

63

argmin𝒙|𝑦 − 𝑓(𝑡, 𝒙, 𝑉)|
Initialization:
Screen parameters to identify control variables 𝒙 =(𝑥1 , … , 𝑥𝑝 )𝑇
Sample 𝑛 design points 𝑿=(𝒙1 ; … ; 𝒙𝑛 ) using the maximin LHD
Evaluate the model output 𝑦̃𝑖 at each design point 𝑿𝒊 , 𝑖=1,…,𝑛
Calculate the model discrepancy from experimental data 𝑦,
𝑧𝑖 = |𝑦𝑖 − 𝑓(𝑡, 𝒙𝒊 , 𝑉)|, for 𝑖 = 1,…, 𝑛
Construct a GP model to estimate the response surface
While discrepancy>MinTol
Sample 𝑚 new design points 𝑿∗=(𝒙∗1 , … , 𝒙∗ 𝑚 ) with the maximin LHD
Predict the model discrepancy 𝜹(𝑿∗ )of 𝑿∗ using the GP model
Calculate the probability of improvement (ProbI) for 𝑿∗
Evaluate the model output at the next design with the maximal ProbI,
𝒙𝑁 = 𝑿∗(max(ProbI)), 𝑧𝑁 = 𝜹∗ (max(ProbI))
𝑿
𝒁
Update the dataset: (𝑿, 𝒁) = ([ ] , [ ])
𝒙𝑁 𝑧𝑁
Update the GP model
End

Figure 3-5 The algorithm for statistical metamodeling and sequential design of computer
experiments.

3.2.5 Algorithmic Summary for Statistical Metamodeling and Sequential Design of Computer
Experiments
As shown in Figure 3-1 and Figure 3-5, the algorithm starts with parameters screening for
identifying control variables 𝒙 = (𝑥1 , … , 𝑥𝑝 )𝑇 that are sensitive to the variations of model
discrepancy. Then, a set of design points 𝑿=(𝒙1 ; … ; 𝒙𝑛 ) is sampled in the 𝑝-dimensional space of
control variables using the maximin Latin Hypercube Design. Based on the outputs 𝑦̃ at each
design point 𝒙𝑖 , 𝑖=1,…,𝑛 calculated from computer model, the discrepancy from real experimental
data is computed as:
𝑧 = |𝑦 − 𝑦̃| = |𝑦 − 𝑓(𝑡, 𝒙, 𝑉)|
Once this dataset is obtained, a GP-based metamodel is built to model the functional relationship
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between model discrepancy and control variables as:
𝑧 = 𝛿(𝒙) + 𝜖
𝛿(𝒙)~𝐺𝑃(𝑚(𝒙), 𝑘(𝒙, 𝒙′ ))
However, the GP model may not be accurate enough to capture the true response surface due
to the scarcity of design points. Therefore, the GP model is iteratively updated by adding a new
design point where the probability to minimize model discrepancy is the highest. This process
iterates until the model discrepancy is lower than a minimal tolerance value (MinTol).
3.3

Cardiac Models and Experimental Protocols

We recently modeled the transition of molecular states in glyco-altered gating of hERG (𝐼𝐾𝑟 )
channels, showing that N-glycosylation effectively limits hERG channel activity. From the insilico models, reduced glycosylation was shown to shorten the repolarization phase of cardiac APs
and impact the electrical conduction in cardiac fibers and tissues [16, 17]. In this present study, we
previously conducted electrophysiological experiments to measure Nav channel activity and APs
of mouse ventricular myocytes using voltage- and current-clamp methods [15]. These experiments
provide two full sets of data; one under “control” (physiological, wild-type - WT) conditions, and
the other under conditions of reduced sialylation (pathology, ST3Gal4−/−). In this section, we will
detail computer models and briefly describe experimental pulse protocols (for details, see Ednie et
al, 15) together which are used to describe mechanistic details of pathological variations in the
𝑁𝑎𝑣 channels and myocyte AP.
3.3.1 Computer Model of Ventricular Myocytes
This present investigation used the computer model of action potential of mouse ventricular
myocytes from Bondarenko and Rasmusson et al [31], which is only for the mouse ventricular
myocytes under “control” (physiological, wild-type - WT) conditions, but is not adequate to model
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the mechanistic details of pathological variations (e.g., ST3Gal4-/-) in the Na+ ion channels and
myocyte AP. The cellular AP is described by the ordinal differential equation:
−𝐶𝑚

𝑑𝑉
= 𝐼𝐶𝑎𝐿 + 𝐼𝑝(𝐶𝑎) + 𝐼𝑁𝑎𝐶𝑎 + 𝐼𝐶𝑎𝑏 + 𝐼𝑁𝑎 + 𝐼𝑁𝑎𝑏 + 𝐼𝑁𝑎𝐾 +
𝑑𝑡

𝐼𝐾𝑡𝑜,𝑓 + 𝐼𝐾𝑡𝑜,𝑠 + 𝐼𝐾1 + 𝐼𝐾𝑠 + 𝐼𝐾𝑢𝑟 + 𝐼𝐾𝑠𝑠 + 𝐼𝐾𝑟 + 𝐼𝐶𝑙,𝐶𝑎 + 𝐼𝑠𝑡𝑖𝑚
where 𝑡 is time, 𝐶𝑚 is the cell capacitance, 𝐼𝑠𝑡𝑖𝑚 is the external stimulus current which activates
the cell from the resting state. The transmembrane currents include the fast 𝑁𝑎 + current (𝐼𝑁𝑎 ), the
L-type 𝐶𝑎2+ current (𝐼𝐶𝑎𝐿 ), the rapidly recovering transient outward 𝐾 + current (𝐼𝐾𝑡𝑜,𝑓 ), the
slowly recovering transient outward 𝐾 + current (𝐼𝐾𝑡𝑜,𝑠 ), the rapid delayed rectifier 𝐾 + current
(𝐼𝐾𝑟 ), the ultrarapidly activating delayed rectifier 𝐾 + current (𝐼𝐾𝑢𝑟 ), the noninactivating steadystate voltage-activated 𝐾 + current (𝐼𝐾𝑠𝑠 ), the time-independent inwardly rectifying 𝐾 + current
(𝐼𝐾1 ), the slow delayed rectifier 𝐾 + current (𝐼𝐾𝑠 ), the 𝑁𝑎+ /𝐶𝑎++ exchange current (𝐼𝑁𝑎𝐶𝑎 ), the
𝑁𝑎+ /𝐾 + pump current (𝐼𝑁𝑎𝐾 ), the 𝐶𝑎2+ pump current (𝐼𝑝(𝐶𝑎) ), the 𝐶𝑎2+ -activated 𝐶𝑙 − current,
ant the background 𝐶𝑎2+ and 𝑁𝑎 + currents. Most ionic currents are modeled using HodgkinHuxley or Markov-based formulations, including the cell conductance, the gradients of membrane
potential and gating dynamics. For details on all the ion-channel kinetics, see [31].
Our objective is to calibrate the model to describe mechanistic details of pathological variations
(i.e., reduced sialylation) in the Na+ ion channels and myocyte AP. Notably, this is not a trivial
task, due to the nonlinear and non-convex characteristics in the complex kinetics of Na+ ion
channels, which will be detailed in the next section.
3.3.2 Computer Model of 𝑁𝑎𝑣 Channels
As shown in Figure 3-6, the Markov model of 𝑁𝑎𝑣 channels includes three close states (C1, C2,
C3), one fast inactivation (IF), one open state (O), two intermediate inactivated states (I1, I2) and
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two closed-inactivation states (IC2, IC3). The transition rates are dependent on the membrane
potential in a non-linear fashion. The state probability denotes the fraction of Na+ channels in that
state. Let P be the vector of state probability:
𝐏 = [𝑃𝐼𝐶3 , 𝑃𝐼𝐶2 , 𝑃𝐼𝐹 , 𝑃𝐼1 , 𝑃𝐼2 , 𝑃𝐶3 , 𝑃𝐶2 , 𝑃𝐶1 , 𝑃𝑂 ]T
The temporal dynamics of 𝑷 are modeled with the following differential equations:
d𝐏(𝑡)
= 𝐀(𝑉) × 𝐏(𝑡)
d𝑡
where 𝐀 is the 9 × 9 transition rate matrix (see the supplement). The diagonal elements in 𝐀 are
the sum of transition rates that transfer out of the current state, e.g. 𝐴1,1 = −(𝛼31 + 𝛼111 ). The offdiagonal elements contain the transition rates that transfer into the current state from other states,
e.g., 𝐴1,2 = 𝛽111 and 𝐴1,6 = 𝛽31. Note that 𝐴1,2 determines the transition rate from IC2 to IC3 (see
Figure 3-6). All non-zero elements in the transition rate matrix 𝐀 are dependent on the membrane
potential (V), thereby making the gating of 𝑁𝑎+ ion channels voltage-dependent. The fast 𝑁𝑎 +
current, 𝐼𝑁𝑎 , is modeled as:
𝐼𝑁𝑎 = 𝐺𝑁𝑎 𝑃𝑂 (𝑡)(𝑉 − 𝐸𝑁𝑎 )
where 𝑃𝑂 (𝑡) is the probability of the 𝑁𝑎 + channels in the open state at time 𝑡, 𝐸𝑁𝑎 is the reverse
potential and 𝐺𝑁𝑎 is the maximum 𝑁𝑎+ conductance.

𝜶𝟏𝟏𝟏
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Figure 3-6 The Markov model of Na+ channels.
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I2

3.3.3 Experimental Protocols
In the electrophysiological experiments, we used standard pulse protocols to measure wholecell current-voltage (I-V), steady state activation (SSA), steady state inactivation (SSI) and
recovery from fast inactivation (REC) of 𝑁𝑎+ channels (see protocol details in the next section).
However, there are slight differences in cell preparation and solutions used between Rasmusson’s
and our electrophysiological experiments. Notably, the reverse potential 𝐸𝑁𝑎 in our experiments
is 20.5mV, instead of 39 mV.
As such, we adjusted the extracellular 𝑁𝑎 + concentration [𝑁𝑎 + ]𝑜 from 140,000 𝜇𝑀 to
66,000 𝜇𝑀 in the computer model to match our experimental setting. All other parameters stay the
same as given in the Bondarenko and Rasmusson et al [31]. The original values of transition rates
in the matrix 𝐀 are used as initial guesses in the process of model calibration. During computer
experiments, we followed the same pulse protocols to identify 2 sets of optimal values of transition
rates in the matrix 𝐀 that minimize the discrepancy between the responses from the simulation
model (i.e., the 9-state Markov model) and 2 sets of experimental data (i.e., control vs. reduced
sialylation conditions).
Experimental data were collected from the left ventricular apex of adult (12-14 weeks old) male
mice homozygous for the normal ST3Gal4 gene (WT, n=11) and for the ST3Gal4 null-transgene
(ST3Gal4-/-, n=13) as described by us previously [15]. ST3Gal4 is a uniformly expressed betagalactoside alpha-2,3-sialyltransferase 4 (ST3Gal4) that is responsible for adding terminal sialic
acids in the 2-3 configuration to N- and O-glycans. The pulse protocols used in both physical
and computer experiments are illustrated in Figure 3-7 and described in the online supplement and
as described in Ednie et al. [15]. The data points in Figure 3-10 ~ Figure 3-12 were as reported in
our previous report [15].
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Figure 3-7 Standard pulse protocols of SSA, SSI and REC.
Current Density-Voltage Relationships and Steady-State Activation (SSA) are measured using
the protocols described as following. Cells were held at -100mV, stepped to a series of voltage
(from -85mV to +30m in 5 increments) for 120ms, and then stepped back to -100mV (see Figure
3-7). Each voltage step was separated by 1.5 seconds. The 𝑁𝑎+ conductance (G) is determined as
𝐺 = 𝐼𝑝𝑒𝑎𝑘 /(𝑉𝑐 − 𝐸𝑁𝑎 ), where 𝐼𝑝𝑒𝑎𝑘 is the peak of 𝑁𝑎+ currents elicited at each clamp voltage 𝑉𝑐 .
The current 𝐼𝑁𝑎 elicited from each test pulse is divided by the cell capacitance to report current
density as A/F. The current density-voltage relationship is obtained by plotting the current density
with respect to the clamp voltage. The maximum conductance 𝐺𝑚𝑎𝑥 generated by each cell was
used to normalize the data. Conductance-voltage relationships were fit with a Boltzmann equation
and the fraction of maximal conductance is:
𝐺/𝐺𝑚𝑎𝑥 =

1
1 + exp(−(𝑉 − 𝑉𝑎 )/𝐾𝑎 )

where 𝑉 is the membrane potentials, 𝑉𝑎 is the half-activation potential, 𝐾𝑎 is the slope factor. The
normalized data were averaged with those from the other cells to calculate the resulting average G–
V curves.
Steady-state inactivation (SSI) is collected following the below protocol. Cells were held at 100 mV and then pre-pulsed to conditioning voltages ranging from -140 mV to -65 mV in 5 mV
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increments for 500 ms. Following the conditioning pulses, the cells were depolarized to -20 mV
for 10 ms (see Figure 3-7). The maximum current generated by each cell was used to normalize
the data, and then fit to a single Boltzmann distribution, from which the mean Vi ±SEM and Ki ±
SEM values were determined. The fraction of maximal currents is:
𝐼/𝐼𝑚𝑎𝑥 =

1
1 + exp((𝑉 − 𝑉𝑖 )/𝐾𝑖 )

where 𝐼/𝐼𝑚𝑎𝑥 is the ratio of each current to the maximum current, 𝑉 is the membrane potential, Vi
is the voltage of half-inactivation, Ki is the slope factor.
Recovery from Fast Inactivation (REC) is measured by the protocol describe here. As shown
in Figure 3-7, cells were held at a voltage of -90mV for a duration of 10ms and then followed by
the first depolarization to -20mV for 50ms (the first pulse). The membrane potential then returned
to -90mV for a variable duration from 10ms to 300ms with 10ms increments followed by a second
depolarization to -20mV for 50ms (the second pulse). The peak currents elicited from the second
pulse to -20 mV was normalized to the current from the initial pulse to -20 mV for measuring the
recovery from fact inactivation of Na+ channels [15].
Cellular Refractory Period is modeled using the same protocol in physical experiments. Cells
were first injected with a 1.4ms 80 pA/pF stimulus current to excite the first AP. The first
stimulation is followed by a second pulse 5ms later and then each additional pulse at an incremental
time interval of 5ms until the emergence of the second similar AP [15]. The time interval between
2 similar APs is used to estimate the refractory period.
Computer models were implemented using the MATLAB R2012a software from MathWorks
(Natick, MA, USA) in a Windows 7 (Microsoft, Redmond, WA, USA) 64-bit machine. Computer
experiments follow the same pulse protocols as in-vitro experiments to compute the model
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responses and to calibrate in-silico models. The models of cardiac cells and 𝑁𝑎+ ion channels are
solved with the use of Ode15s solver at a maximal step size of 1ms.
Table 3-1 Transition rates of the Markov Model.
Transition Rates (𝑚𝑠 −1)
𝛼11=3.802(0.1027exp(-(V+𝑥1 )/17.0) +0.20exp(-(V+ 𝑥1 )/150.0))-1
𝛽 11= 0.1917exp(-(V+𝑥2 )/20.3)
𝛼12=3.802(0.1027exp(-(V+ 𝑥3 )/15.0) + 0.23exp(-(V+ 𝑥3 )/150.0))-1
𝛽 12= 0.20exp(-(V+𝑥4 )/20.3)
𝛼13=3.802(0.1027exp(-(V+ 𝑥5 )/12.0) + 0.25exp(-(V+ 𝑥5 )/150.0))-1
𝛽 13= 0.22exp(-(V+𝑥6 )/20.3)
𝛼111=3.802(0.1027exp(-(V+𝑥7 )/17.0) + 0.20exp(-(V+ +𝑥7 )/150.0))-1
𝛼112=3.802(0.1027exp(-(V+ 𝑥8 )/15.0) + 0.23exp(-(V+𝑥8 )/150.0))-1
𝛽 111= 0.1917exp(-(V+𝑥9 )/20.3)
𝛽 112= 0.20exp(-(V+𝑥10 )/20.3)
𝛼31= 7.0e-7exp(-(V+𝑥11 )/(7.7+𝑥23 ))
𝛽 31 = 0.0084 +𝑥12 + 2e-5(V+7.0)
𝛼32= 7.0e-7exp(-(V+𝑥13 )/ (7.7+𝑥24 ))
𝛽 32 = 0.0084 +𝑥14 + 2e-5(V+7.0)
𝛼33= 7.0e-7exp(-(V+𝑥15 )/(7.7+𝑥25 ))
𝛽 33 = 0.0084 + 𝑥16 +2e-5(V+7.0)
𝛼2= 0.188495exp(-(V+𝑥17 )/(16.6+𝑥22 ) + 0.393956)
𝛽 2 = 𝛼 13 𝛼 2 𝛼 33/( 𝛽 13 𝛽 33)
𝛼4= 𝑥18 𝛼 21e-3
𝛽 4 = 𝑥19 𝛼 33
𝛼5= 𝑥20 𝛼2/95000
𝛽 5 = 𝑥21 𝛼 33/50

3.4

Results

3.4.1 Parameter Screening
As shown in Section 3.2, the 9-state Markov model of Nav channels involves 22 transition rates,
each of which is voltage-sensitive. Table 3-2 shows the detailed model of 22 transition rates. We
performed a preliminary sensitivity analysis to screen parameters that have potential impacts on
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the model responses from three pulse protocols, i.e., SSA, SSI and REC. As shown in Table 3-1,
we empirically identify a set of 25 potential parameters for further screening (i.e., 𝑥𝑖 , 𝑖 = 1, ⋯ ,25).
The screening design is aimed at identifying a low-dimensional set of important control variables
(i.e., sensitive to the model responses to pulse protocols) from the high-dimensional set of potential
model parameters so as to facilitate the process of statistical metamodeling.
Table 3-2

𝑥1
𝑥2
𝑥3
𝑥4
𝑥5
𝑥6
𝑥7
𝑥8
𝑥9
𝑥10
𝑥11
𝑥12
𝑥13

Experimental parameters and levels in transition rates.

0

+1

-1

2.5
2.5
2.5
-2.5
2.5
-7.5
2.5
2.5
2.5
-2.5
7
0
7

7.5
7.5
7.5
2.5
7.5
-2.5
5
7.5
5
2.5
12
0.001
12

-2.5
-2.5
-2.5
-7.5
-2.5
-12.5
0
-2.5
0
-7.5
2
-0.001
2

𝑥14
𝑥15
𝑥16
𝑥17
𝑥18
𝑥19
𝑥20
𝑥21
𝑥22
𝑥23
𝑥24
𝑥25

0

+1

-1

0
7
0
7
1
1
1
1
0
0
0
0

0.001
12
0.001
12
10
10
10
10
1.66
1
1
1

-0.001
2
-0.001
2
1
1
1
1
-1.66
-1
-1
-1

In order to reduce the computational cost, we adopted a 1024-run 225−15
fractional factorial
V
design for the sensitivity analysis of parametric effects on response functions. The resolution
ensures that the main effects are strongly clear and the two-factor interactions are clear. Each
parameter is varied at two levels of high (+1) and low (-1). Table 3-2 shows the values of each
parameter at +1 and -1 levels, which are empirically determined based on the original values (0)
in the Bondarenko and Rasmusson et al. [31].
Notably, the computational speed for each run in the SSA, SSI and REC experiments is about
1.90s, 4.20s and 8.06s, respectively. A full factorial design (FD) will require 225 runs to screen
72

the effect of all possible combinations of +1’s and -1’s, which is computationally expensive and
time consuming. As such, the full factorial design is not efficient, even infeasible, for a highdimensional space of parameters. As shown in Table 3-3, the time durations of full FD are 1.77e4
hrs, 3.91e4 hrs and 7.51e4 hrs for SSA, SSI and REC experiments, respectively. However, the
fractional FD is more efficient, and only need 32.42mins, 71.68mins and 137.56mins.
Table 3-3

Unit time/ run
Full FD
Fractional FD

Comparison of computational time for screening designs.
Runs
1
225
210

SSA
SSI
REC
1.90s
4.20s
8.06s
1.77e4 hrs
3.91e4 hrs
7.51e4 hrs
32.42 mins 71.68 mins
137.56 mins
∗ s: second; hrs: hours; mins: minutes

After obtaining computed responses from the 1024-run experiments on computer models, we
estimated the factorial effects of parameters using the linear model. Figure 3-8 shows the halfnormal probability plots for factorial effects of 25 parameters in SSA, SSI and REC protocols,
respectively. Note that half-normal probability plot is a graphical method to test the significance
of factorial effects. The significant effects will fall above the straight line of small factorial effects
and appear in the upper right corner of the plot. As shown in Figure 3-8, the set of parameters
{𝑥1 , 𝑥2 , 𝑥3 , 𝑥4 , 𝑥5 , 𝑥6 , 𝑥17 , 𝑥22 } has significant effects for steady-state activation. Similarly,
{𝑥11 , 𝑥12 , 𝑥23 } and potentially {𝑥13 , 𝑥14 , 𝑥24 } are significant on the responses of steady-state
inactivation. In addition, the set of parameters {𝑥11 , 𝑥12 , 𝑥15 , 𝑥18 , 𝑥19 , 𝑥23 , 𝑥25 } has significant
impacts on the recovery from fast inactivation.
In addition to half-normal plots, we used the Lenth’s method [32] to quantitatively test effect
significance in the experiments. The pseudo standard error (PSE) of factorial effects β̂i ′𝑠 is
calculated as:
PSE = 1.5×median
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Figure 3-8 Half-normal probability plots for factorial effects of 25 model parameters in SSA, SSI
and REC protocols.
where s0 = 1.5 × median|β̂i |. Note that PSE is an estimator of the standard deviation of β̂i ′𝑠.
After dividing the β̂i ′𝑠 by the PSE, we obtain the t-like statistics:
t PSE,i =

β̂i
PSE

Under the null hypothesis 𝐻0 that all β̂i ′𝑠 are not significant, we have the critical region:
prob(|t PSE,i | > 𝜇𝛼 |𝐻0 ) = α
where μα is the critical value at the significant level of α. An effect β̂i is declared to be significant
if |t PSE,i| is greater than the critical value μα . The critical value of Lenth’s method (𝜇𝛼 = 4.82) at
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a significant level (𝛼 = 0.001) is available in most statistical software, e.g. SAS, Minitab.
The quantitative test confirms the results obtained from the graphical method and identifies
three sets of control variables:
𝒙𝑆𝑆𝐴 = {𝑥1 , 𝑥2 , 𝑥3 , 𝑥4 , 𝑥5 , 𝑥6 , 𝑥17 , 𝑥22 }
𝒙𝑆𝑆𝐼 = {𝑥11 , 𝑥12 , 𝑥13 , 𝑥14 , 𝑥23 , 𝑥24 }
𝒙𝑅𝐸𝐶 = {𝑥11 , 𝑥12 , 𝑥15 , 𝑥18 , 𝑥19 , 𝑥23 , 𝑥25 }
Figure 3-9 shows the sensitivity plot of transition rates in SSA, SSI and REC protocols. The
results of screening experiments show that 𝛼11 , 𝛽11 , 𝛼12 , 𝛽12 , 𝛼13 , 𝛽13 , and 𝛼2 have greater
impacts on SSA, but are less sensitive to SSI and REC. It is also shown that 𝛼31 , 𝛽31, 𝛼32 and 𝛽32
are more sensitive to the SSI than other transition rates, and have similar impacts on REC. In
addition, we found that 𝛼33 , 𝛼2 , 𝛼4 and 𝛽4 are sensitive to the REC protocols.
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Figure 3-9 Sensitivity of transition rates in SSA, SSI and REC protocols.
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Based on the results of screening experiments, we categorized the control variables into two
groups. The first group includes those variables sensitive to SSA (i.e., 𝒙𝑆𝑆𝐴 =
{𝑥1 , 𝑥2 , 𝑥3 , 𝑥4 , 𝑥5 , 𝑥6 , 𝑥17 , 𝑥22 }), and the second group includes those variables sensitive to both
SSI and REC, i.e.,
𝒙𝑆𝑆𝐼+𝑅𝐸𝐶 = {𝑥11 , 𝑥12 , 𝑥13 , 𝑥14 , 𝑥15 , 𝑥18 , 𝑥19 , 𝑥23 , 𝑥24 , 𝑥25 }
Therefore, the high-dimensional space of parameters is reduced to two sets of low-dimensional
control variables. In addition, the problem of multi-objective optimization is decomposed into
modular optimization formulations with a low-dimensional space of control variables.
3.4.2 Steady State Activation
Furthermore, we approximated the SSA discrepancy between computer model and
electrophysiological data using the easy-to-evaluate statistical metamodels. First, we used the
maximin Latin Hypercube Design (also see Section 3.2.2) to generate 20 design points of SSA
control variables 𝒙𝑆𝑆𝐴 = {𝑥1 , 𝑥2 , 𝑥3 , 𝑥4 , 𝑥5 , 𝑥6 , 𝑥17 , 𝑥22 } , and then run the computer model to
compute the responses. We fit the Gaussian Process metamodel to the data, then the metamodel is
iteratively updated by adding a new design point where the probability to minimize model
discrepancy is the highest. This process iterates until the SSA discrepancy is lower than a minimal
tolerance value (i.e., MinTol=0.004 in this present study).
Figure 3-10 show steady state activation and inactivation under WT (i.e., control) and ST3Gal4/-

in ventricular myocytes. It may be noted that the SSA in ST3Gal4-/- myocytes is shifted toward

a more depolarized potential than the WT. The experimental results show the shift of ~5mV. As
shown in Figure 3-10, the SSA relationships from computer model match the trend of experimental
data. It is remarkable that metamodel-based optimization converges to the minimum of the
response surface very quickly (~100 iterations).
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Figure 3-10 Steady state activation and inactivation for wild-type and ST3Gal4-/- conditions.
3.4.3 Steady State Inactivation and Recovery from Fast Inactivation
As mentioned in Section 3.4.1, we found that there are some common parameters sensitive to
both SSI and REC.
𝒙𝑆𝑆𝐼 = {𝑥11 , 𝑥12 , 𝑥13 , 𝑥14 , 𝑥23 , 𝑥24 }
𝒙𝑅𝐸𝐶 = {𝑥11 , 𝑥12 , 𝑥15 , 𝑥18 , 𝑥19 , 𝑥23 , 𝑥25 }
Therefore, we will minimize the model discrepancy for both SSI and REC protocols in the second
stage of the optimization process. The combined set of control variables is:
𝒙𝑆𝑆𝐼+𝑅𝐸𝐶 = {𝑥11 , 𝑥12 , 𝑥13 , 𝑥14 , 𝑥15 , 𝑥18 , 𝑥19 , 𝑥23 , 𝑥24 , 𝑥25 }
Statistical metamodels are constructed to approximate the relationship between 𝒙𝑆𝑆𝐼+𝑅𝐸𝐶 and model
discrepancy (i.e., between experimental data and model responses under both SSI and REC
protocols). Similarly, we used the statistical model as a surrogate to iteratively search a new design
point where the probability to minimize model discrepancy is the highest. The original values of
control variables 𝒙𝑆𝑆𝐼+𝑅𝐸𝐶 , given in the Bondarenko and Rasmusson et al [31], are used as initial
guesses in the process of model calibration. The minimal tolerance of SSI+REC discrepancy is set
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to be 0.04. Note that SSI+REC experiments take more iterations (~1000 iterations) than SSA in the
process to identify the optimal values of control variables because of the higher dimension of design
space as well as two joint constraints of SSI+REC protocols.
However, statistical metamodeling and sequential design significantly improve the speed of
convergence. As mentioned, if we treat the computer model as a blackbox, traditional linear and
nonlinear optimization methods become very difficult or even infeasible, for calibrating the model
in the high-dimensional design space. It is worth mentioning that the time cost to evaluate 1000
design points is only 0.040 seconds for the statistical GP model, but 2.75 hours for the computer
model. Hence, it is a significant advantage to adopt the statistical metamodeling and sequential
design strategy of computer experiments, especially for large-scale simulation models that are
computationally expensive and time consuming.
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Figure 3-11 Recovery from fast inactivation of WT and ST3Gal4-/- cells.

Figure 3-10 shows that the calibrated model captures SSI relationships in the experimental data
for both WT and ST3Gal4-/- myocytes. As shown in Figure 3-10, there is a depolarizing shift of
~4 mV in voltage-dependent SSI for ST3Gal4−/− myocytes compared to WT myocytes. This
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indicates that ST3Gal4 gene deletion leads to the requirement of a greater depolarization for the
inactivation of the Nav channels. In addition, Figure 3-11 shows that the recovery from fast
inactivation from the computer model fits the experimental data. However, there are slight misfits
in some portions of REC data due to the random effects in real-world electrophysiological
experiments.
Table 3-4 Optimal values of control variables for WT and ST3GAL4-/- cells.
WT
𝒙𝟏
𝒙𝟐
𝒙𝟑
𝒙𝟒
𝒙𝟓
𝒙𝟔
𝒙𝟏𝟏
𝒙𝟏𝟐
𝒙𝟏𝟑

16.3036
23.6605
8.0636
14.8590
31.0464
-0.2266
19.6572
0.0052
28.3559

ST3Gal4-/-

WT

38.9756
27.6129
8.2235
10.7454
25.6248
-6.6274
17.0064
0.0046
31.8518

𝒙𝟏𝟒
𝒙𝟏𝟓
𝒙𝟏𝟕
𝒙𝟏𝟖
𝒙𝟏𝟗
𝒙𝟐𝟐
𝒙𝟐𝟑
𝒙𝟐𝟒
𝒙𝟐𝟓

0.0055
28.6912
12.3515
3.3553e2
4.3636e3
-3.3326
-0.4042
-0.4496
-0.1292

ST3Gal4-/0.0041
29.3783
16.9279
8.4621e2
7.4270e3
-3.1787
-0.5177
-0.5496
-1.2045

Table 3-4 shows optimal values of control variables, 𝒙𝑆𝑆𝐴 , 𝒙𝑆𝑆𝐼 , and 𝒙𝑅𝐸𝐶 for the calibrated
models of 𝑁𝑎𝑣 channels isolated from WT and ST3Gal4-/- myocytes. Note that there are
significant differences between these two sets of optimal values for control variables. However,
calibrated models best fits the WT and ST3Gal4-/- experimental data with standard pulse protocols
(i.e., SSA, SSI, and REC).
3.4.4 Model Validation
These two set of parameters, shown in Table 3-4, yield best fit of WT and ST3Gal4-/experimental data obtained from SSA, SSI and REC protocols. As such, we have two initial
versions of calibrated models for WT and ST3Gal4-/- myocytes. In order to validate calibrated
models, we further measured model responses of current-voltage relationships and cellular
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refractory period, and made a comparison with real experimental data, which are detailed as
follows.
Current density-voltage relationship is modeled in this study using conventional protocols.
Following the pulse protocols in Section 3.3.3, we computed the response of 𝐼𝑁𝑎 from calibrated
models (both ST3Gal4-/- and WT myocytes) for each test pulse. The current density-voltage
relationship is obtained by plotting the current density with respect to the clamp voltage.
As shown in Figure 3-12, 𝐼𝑁𝑎 current densities from the model of ST3Gal4-/- myocytes are
bigger than in WT myocytes at relatively small depolarization, i.e., when cells are held at -100mv
and then stepped to the voltages between -70mv and -30mv. However, there are no significant
effects at greater depolarization. Note that the discrepancy of current density-voltage relationships
between computer models and experimental data is minimized for both ST3Gal4-/- and WT
myocytes. These results showed that computer models are well-calibrated and suggested that the
gating dynamics of 𝑁𝑎𝑣 channels differently with ST3Gal4 expression.
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Figure 3-12 Current density-voltage relationships.

Cellular Refractory Period is compared between ST3Gal4-/- and WT conditions. We have also
integrated the calibrated models of 𝑁𝑎 + channels into the ventricular cell model to predict whether
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and how ST3Gal4 gene deletion influences the electrical activity of cardiac cells. It should be
noted that the 𝑁𝑎 + channels are responsible for the excitation of cells and also contributes to
electrical conduction in tissues. 𝑁𝑎𝑣 recovery from fast inactivation is closely pertinent to the
cellular refractory period.
Figure 3-13 shows the responses of ventricular cell models using the refractory-period protocol
(also see Section 3.3.3). Notably, there are significant differences in the cellular refractory periods
from computer models of ST3Gal4-/- and WT myocytes. However, resting membrane potentials
and AP durations do not show significant differences between computer models of ST3Gal4-/- and
WT myocytes. In addition, our experimental results demonstrated that the model of ST3Gal4-/myocytes yields a 28.5ms shorter refractory period than WTs. In contrast, our electrophysiological
experiments also show that the refractory periods are approximately 110.2 ± 10.0 ms (n=13) for
ST3Gal4-/- cells, and 139.8 ± 8.6 ms for WTs (n=11), i.e., 29.6ms shorter refractory period in
ST3Gal4-/- cells [15]. These results show the validity of computer models to capture the
mechanistic details of 𝑁𝑎+ electrical signaling, as well as the effectiveness of the proposed
algorithms for calibrating computer models.
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Figure 3-13 Cellular refractory periods from computer models of ST3Gal4-/- and WT myocytes.
(WT: 138.0ms, ST3Gal4-/-: 109.5ms)
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3.4.5 State Transitions in 𝑁𝑎𝑣 Channels
Although electrophysiological experiments can observe aberrant electrical signaling in reduced
sialylation with the use of standard pulse protocols, understanding mechanistic details of ST3Gal4/-

pathological variations in 𝐼𝑁𝑎 and AP is difficult without performing in-silico studies. In-vitro

experiments can measure ionic currents 𝐼𝑁𝑎 and AP with voltage and current clamp protocols, but
preclude us from determining directly the change in transitions among molecular states (e.g., open,
close, intermediate inactivated, and fast inactivated states) and their systematic contributions to AP
variations. In this section, we will use the calibrated in-silico models to predict the variations of
mechanistic details in the state transitions and distributions of 𝑁𝑎+ Channels for both ST3Gal4-/and WT myocytes.
As shown in Figure 3-14, there are significant variations in the state transitions of 𝑁𝑎 +
Channels under ST3Gal4-/- and WT conditions. During the AP upstroke (Figure 3-14a), ST3Gal4/-

channels open slightly faster and wider than WT (i.e., 20% vs. 15%). This also leads to a shorter

time-to-peak value for ST3Gal4-/- channels. It may also be noted that WT channels have a higher
probability in the fast inactivation (IF), 38% vs. 27%, but a slower transition to the intermediate
inactivation (I1) than ST3Gal4-/- channels, i.e., 2% vs. 4%.
At the peaks of APs (Figure 3-14b), ST3Gal4-/- channels show a more significant probability to
stay in the intermediate inactivation (I1) than WTs (i.e., 67% vs. 40%), whereas most of WT
channels are still in the state of Fast Inactivation (IF). This indicates that ST3Gal4-/- channels have
a faster transition from the IF to the I1 state, and thereby a smaller probability of remaining in the
IF state than WT channels (i.e., 27% vs. 55%). Also, it may be noted that both channels have a
small probability (see Figure 3-14 b) in the open state (6% in ST3Gal4-/- channels and 4% in WT
channels).
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Figure 3-14 State transitions of sodium channels during the course of action potential under WT
and ST3Gal4-/- conditions.
In the late repolarization phase (Figure 3-14c), all the ST3Gal4-/- channels exited the state of
intermediate inactivation (I1), but WT channels have 10% remaining in the I1 state. Most
importantly, ST3Gal4-/- channels have a higher probability in the closed-inactivation state (IC3)
than WTs (i.e., 87% vs. 77%). This suggests that ST3Gal4-/- channels have a faster transition from
I1 state to IC3 state.
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After 50ms (Figure 3-14d), both ST3Gal4-/- and WT APs are at the end of the repolarization
phase and reach the level of resting potential. In addition, both ST3Gal4-/- and WT channels have
completely exited the open, fast inactivation and intermediate inactivation states. Figure 3-14c
shows that ST3Gal4-/- channels have a smaller probability of remaining in the closed-inactivation
state (IC3) than WTs (i.e., 85% vs. 91%). Further, it is shown that ST3Gal4-/- channels enters the
close state earlier than WTs (ST3Gal4-/-: C3=8% and C2=5%; WT: C3=6% and C2=1%).
This trend continues for ST3Gal4-/- and WT channels after 100ms (Figure 3-14e), and more and
more ST3Gal4-/- channels enters the close state earlier than WTs. This indicates that ST3Gal4-/channels get ready for the second stimulation earlier than WTs. Hence, in-silico models provide
the underlying mechanistic details that explain why ST3Gal4-/- cells have shorter refractory periods.
3.5

Conclusions

This study presents a new statistical metamodeling approach for efficient computer experiments
and optimization of 𝑁𝑎𝑣 models to describe glyco-altered Nav gating kinetics in the ST3Gal4−/−
heart. Note that voltage-gated sodium (𝑁𝑎𝑣 ) channel activity is responsible for the excitation of
cells and also contributes to electrical conduction in tissues. In addition, 𝑁𝑎𝑣 ion channels are
heavily glycosylated, with up to 35% of a mature protein’s mass comprised of glycan structures.
There is a set of >40 distinct forms of inherited human diseases of reduced glycosylation known
as Congenital Disorders of Glycosylation, which often leads to severe cardiac deficits, but the
mechanisms are not yet understood.
We have conducted a series of electrophysiological experiments to investigate whether and how
reduced glycosylation affects Nav activity and cardiac electrical signaling. Our experiments
provide two full sets of data; one under “control” (physiological, wild-type - WT) condition, and
the other under the condition of reduced sialylation (pathology, ST3Gal4-/-). Although we observed
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aberrant electrical signaling in reduced sialylation, understanding mechanistic details of
pathological variations in INa and AP is very difficult without performing in-silico studies.
This study presents our efforts to couple in-silico studies with the wealth of experimental data
to model, mechanistically, how reduced glycosylation that occurs in the ST3Gal4−/− heart affects
Nav activity and cardiac electrical signaling. Note that computer model of Nav channels and
cardiac myocytes poses significant challenges for computer experiments and model calibration,
including (1) the high dimensionality of design space, (2) nonlinear and non-convex model
characteristics, (3) a variety of cardiac functional responses from pulse protocols, and (4) specific
kinetics and physical constraints in cardiac ion channels and cells. If the computer model is treated
as the black-box, traditional linear and nonlinear optimization methods have encountered many
difficulties, even infeasible, for calibrating the model in the high-dimensional design space.
Hence, this present investigation employs the statistical metamodel as a surrogate for efficient
and effective calibration of cardiac models. First, we designed the fractional factorial experiments
to identify control variables that are sensitive to the model response functions, and thereby
identifying a low-dimensional set of important control variables from the high-dimensional set of
potential model parameters so as to facilitate the process of statistical metamodeling. Second, we
develop the Gaussian Process models as the surrogates of expensive and time-consuming computer
models and then identify the next best design point that yields the maximal probability of
improvement. The improvement is defined as the discrepancy between real data and model outputs
under standard pulse protocols. This process is iterated until convergence.
Experimental results demonstrated the efficiency and effectiveness of the proposed algorithms
for calibrating computer models, especially for large-scale simulation models that are
computationally expensive and time consuming. The process of model calibration quickly
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converges (<1000 iterations) to the best fits of experimental data of SSA, SSI and REC
relationships for both WT and ST3Gal4-/- conditions. In addition, we evaluated and validated the
calibrated models with the use of current density-voltage relationships and cellular refractory
period. These results show computer models effectively capture the mechanistic details of 𝑁𝑎+
gating dynamics and cellular electrical signaling. Further, we used the calibrated in-silico models
to predict the variations of mechanistic details in the state transitions and distributions of 𝑁𝑎+
Channels for both ST3Gal4-/- and WT myocytes. In-silico models provide the underlying
mechanistic details that explain why ST3Gal4-/- cells have shorter refractory periods than WTs, as
well as why ST3Gal4-/- channels get ready for the second stimulation earlier than WTs.
This study made an attempt to bridge the gaps in statistical metamodeling between engineering
and cardiac domains. As opposed to traditional linear and nonlinear optimization methods, this
study presents a new sequential design of computer experiments for calibrating complex models
of cardiac systems (e.g., Na+ ion channels). The proposed methodology is generally extensible to
many other disciplines that involve the simulation experiments on large-scale and expensive
computer models.
3.6
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Chapter 4 In-Silico Modeling of Glycosylation Modulation Dynamics in K+ Ion Channels
and Cardiac Signaling
Cardiac action potentials (AP) are produced by the orchestrated functions of ion channels. A
slight change in ion channel activity may affect the AP waveform, thereby potentially increasing
susceptibility to abnormal cardiac rhythms. Cardiac ion channels are heavily glycosylated, with up
to 30% of a mature protein’s mass comprised of glycan structures. However, little is known about
how reduced glycosylation impacts the gating of K+ channels. Moreover, decomposing
experimentally the joint K+ current is quite difficult because K+ channels activate at similar range
of voltage, and share overlapping kinetics. The proposed decomposition method takes advantage
of computer models of K+ channels, and describes the fine-grained details of specific currents. As
such, it enables the interpretation of glycosylation modulation dynamics in the gating of each
individual K+ channel. This work suggests new pharmaceutical targets for the glycan-altered
cardiac diseases and potentially other cardiac disorders.
4.1

Introduction

Action potential (AP), the net change of transmembrane potential in a cardiac myocyte during
a contraction cycle, is produced by the orchestrated function of ion channels. A slight change in
ion channel activity may affect the AP waveform and electrical conduction, thereby potentially
lead to severe cardiac disorders. Voltage-gated potassium (𝐾𝑣 ) channels play significant role in
forming the AP. The shape and the duration of the AP are determined by the activities of each
individual 𝐾𝑣 channels, and the diverse distribution of 𝐾𝑣 channels has essential physiological
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functions. In large mammals, there are different types of 𝐾𝑣 isoforms that are responsible for
different phases of the cardiac electrical activity. Figure 4-1 shows the AP waveforms of human
(A) and mouse (B) ventricular myocytes and the currents that contribute to different phases of the
APs. The two main 𝐾𝑣 isoforms: 𝐾𝑣 11.1 and 𝐾𝑣 7.1 affect the ventricular repolarization by
contributing to 𝐼𝐾𝑟 and 𝐼𝐾𝑠 currents during phase 2 through 3 of the AP [1, 2, 6]. The activities of
these 2 isoforms enable long sustained 𝐾 + currents that allow cardiac cells to stay at depolarization
phase for a relatively long time. The 4 isoforms: 𝐾𝑣 4.2/𝐾𝑣 4.3, 𝐾𝑣 1.5 and 𝐾𝑣 2.1 contribute to a
rapid repolarization in mouse ventricles [3, 6]. 𝐾𝑣 4.3 is also found in human ventricular mycytes,
and is responsible for a smaller portion of repolarization [2, 4, 6]. In mouse ventricle, the phase 2
and 3 of the AP are controlled by the rapidly inactivating 𝐾 + current 𝐼𝑡𝑜 , which is contributed by
the isoform of 𝐾𝑣 4.2/4.3, and the slowly inactivating currents:𝐼𝐾𝑠𝑙𝑜𝑤1 , and 𝐼𝐾𝑠𝑙𝑜𝑤2 which are likely
conducted through 𝐾𝑣 1.5 and 𝐾𝑣 2.1 respectively [3, 6].
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Figure 4-1 Modeled APs in human and mouse ventricular myocytes. Human AP is calculated with
ten Tusscher et al. model [29], Mouse AP is calculated with Bondarenko et al. model [30].
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Studies have shown that sialic acids have similar effect on 𝐾𝑣 activities. As we mentioned in
Chapter 2, 𝑁𝑎𝑣 channels can be extensively post-translationally modified by protein glycosylation
through isoform-specific mechanisms [7-12]. The sialic acids have similar functional effects on
𝐾𝑣 isoforms. In 1996 Thornhill et al., found that the 𝐾𝑣 1.1 isoform in rat cardiac cells could be
functionally affected by sialylation [13-15, 6]. Later, similar effects were observed at the single
channel level [16]. The role of sialylation in 𝐾𝑣 1.2 function was investigated through a novel
approach, i.e. mutants were created where glycosylation sites were added to the channel compared
with the function of healthy cells. This study found that N-linked deficient mutant led to a
depolarizing shift in 𝑉𝑎 , a broadening of the slope of the G-V curve and decreased channel kinetics
[6,17]. Recently, Schwetz et al. investigated the effect of sialylation on the heterologously
expressed 𝐾𝑣 isoforms 𝐾𝑣 2.1, 𝐾𝑣 4.2 and 𝐾𝑣 4.3 [18].
In order to answer whether and how reduced glycosylation affects 𝐾𝑣 activity and cardiac
electrical signaling, in-vitro experiments were conducted to measure and characterize potassium
currents. Although we observed aberrant electrical signaling in ST3Gal4-/- ventricular myocytes
and across the ST3Gal4-/- ventricle, understanding mechanistic details of pathological variations
in 𝐾 + currents and AP is very challenging without performing in-silico studies. There are 6
different type of 𝐾 + currents in mouse ventricular myocytes, i.e., a rapid transient outward 𝐾 +
current (𝐼𝑡𝑜 ), a rapid delayed rectifier 𝐾 + current (𝐼𝐾𝑟 ), an ultra-rapidly activating delayed rectifier
𝐾 + current (𝐼𝐾𝑢𝑟 ), a non-inactivating steady-state 𝐾 + current (𝐼𝑠𝑠 ), a very small slow delayed
rectifier current (𝐼𝐾𝑠 ), and a time-independent 𝐾 + current (𝐼𝐾1 ) [19]. Decomposing the joint
𝐾 + current, 𝐼𝐾,𝑠𝑢𝑚 , experimentally is quite difficult because 𝐾𝑣 channels activate at similar range
of voltage, and share overlapping kinetics [20-22]. Experiments can measure the joint 𝐾 + ionic
currents and AP with voltage and current clamp protocols, but preclude us from determining
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directly the systematic contributions of each individual 𝐾 + current to AP variations. There is an
urgent need to integrate computer models with experimental data to model the variations of state
transitions under conditions of reduced sialylation, and the resulting changes in ionic currents and
AP.
In this present study, we propose to couple in-silico studies with the wealth of data from our
electrophysiological experiments to model, mechanistically, how reduced sialylation that occurs
in the ST3Gal4−/− heart affects 𝐾𝑣 channel activity and electrical signaling in the adult mouse
ventricle. Indeed, computer models not only overcome practical and ethical limitations in physical
experiments but also provide predictive insights into the underlying mechanisms.
4.2

Mouse Ventricular Models

In Chapter 3, we modeled the transition of molecular states in ST3Gal4-/- 𝑁𝑎𝑣 channels and
myocytes, showing that glyco-gene defect affects 𝑁𝑎𝑣 channel activity and leads to shortened
refractory periods. In-silico study showed the detailed state transitions under both ST3Gal4-/- and
WT conditions. In addition, computer experiments predict how the changes at molecular level, i.e.,
𝑁𝑎𝑣 channel level, affect the electrical activity at cellular level, i.e., altered channel activities cause
shortened refractory periods in mouse ventricular myocytes. In this chapter, electrophysiological
experiments have been conducted to measure how glyco-gene defect affects the 𝐾𝑣 channel
activity and APs of mouse ventricular myocytes. These experiments produced two sets of data;
one under “control” (physiological, wild-type - WT) conditions, and the other under conditions of
reduced sialylation (pathology, ST3Gal4-/-). In this section, we will detail computer models that
are used to describe mechanistic details of pathological variations in 𝐾𝑣 channels and the AP of
ventricular myocyte. With the computer model, changes in ion channels are modeled, and effect
on cardiac function at cellular level is predicted.
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4.2.1 Computer Model of Ventricular Myocyte
In this present investigation we applied the computer model of action potential of mouse
ventricular myocytes from Bondarenko and Rasmusson et al [23]. The cellular AP is described by
the ordinal differential equation:
−𝐶𝑚

𝑑𝑉
= 𝐼𝐶𝑎𝐿 + 𝐼𝑝(𝐶𝑎) + 𝐼𝑁𝑎𝐶𝑎 + 𝐼𝐶𝑎𝑏 + 𝐼𝑁𝑎 + 𝐼𝑁𝑎𝑏 + 𝐼𝑁𝑎𝐾 +
𝑑𝑡

𝐼𝐾𝑡𝑜,𝑓 + 𝐼𝐾𝑡𝑜,𝑠 + 𝐼𝐾1 + 𝐼𝐾𝑠 + 𝐼𝐾𝑢𝑟 + 𝐼𝐾𝑠𝑠 + 𝐼𝐾𝑟 + 𝐼𝐶𝑙,𝐶𝑎 + 𝐼𝑠𝑡𝑖𝑚
where 𝑡 is time, 𝐶𝑚 is the cell capacitance, 𝐼𝑠𝑡𝑖𝑚 is the external stimulus current which activates
the cell from the resting state. The transmembrane currents include the fast 𝑁𝑎 + current (𝐼𝑁𝑎 ), the
L-type 𝐶𝑎2+ current (𝐼𝐶𝑎𝐿 ), the rapidly recovering transient outward 𝐾 + current (𝐼𝐾𝑡𝑜,𝑓 ), the
slowly recovering transient outward 𝐾 + current (𝐼𝐾𝑡𝑜,𝑠 ), the rapid delayed rectifier 𝐾 + current
(𝐼𝐾𝑟 ), the ultrarapidly activating delayed rectifier 𝐾 + current (𝐼𝐾𝑢𝑟 ), the non-inactivating steadystate voltage-activated 𝐾 + current (𝐼𝐾𝑠𝑠 ), the time-independent inwardly rectifying 𝐾 + current
(𝐼𝐾1 ), the slow delayed rectifier 𝐾 + current (𝐼𝐾𝑠 ), the 𝑁𝑎+ /𝐶𝑎++ exchange current (𝐼𝑁𝑎𝐶𝑎 ), the
𝑁𝑎+ /𝐾 + pump current (𝐼𝑁𝑎𝐾 ), the 𝐶𝑎2+ pump current (𝐼𝑝(𝐶𝑎) ), the 𝐶𝑎2+ -activated 𝐶𝑙 − current,
ant the background 𝐶𝑎2+ and 𝑁𝑎 + currents. Most ionic currents are modeled using HodgkinHuxley or Markov-based formulations, including the cell conductance, the gradients of membrane
potential and gating dynamics. For details on all the ion-channel kinetics, see Bondarenko and
Rasmusson et al [23].
The objective is to calibrate the model to describe the detailed mechanism of 𝐾𝑣 channels and
APs under both ST3Gal4-/- and WT conditions. Notably, there are six different types of K+ currents
that activate at similar range of voltage, and share overlapping kinetics [20-22]. The challenges of
this investigation are posed by multiple K+ currents and the complex kinetics of 𝐾𝑣 channels.
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4.2.2 Computer Model of 𝐾𝑣 Channels
In the mouse ventricular cell, there are several different types of K+ currents, i.e., Rapidly
inactivating transient outward K+ current (𝐼𝐾𝑡𝑜,𝑓 ), Slow-inactivating transient outward K+ current
(𝐼𝐾𝑡𝑜,𝑠 ), Rapid delayed rectifier K+ current (𝐼𝐾𝑟 ), ultra-rapidly activating delayed rectifier K+
current (𝐼𝐾𝑢𝑟 ), non-inactivating steady-state K+ current (𝐼𝐾𝑠𝑠 ), slow delayed-rectifier K+ current
(𝐼𝐾𝑠 ), and time-independent K+ current (𝐼𝐾1 ) [23]. The 𝐼𝐾𝑡𝑜,𝑠 only exists in the septal cells of
mouse ventricle. In this present study, we are investigating the effects of reduced glycosylation on
the 𝐾𝑣 channels in apical cells, so 𝐼𝐾𝑡𝑜,𝑠 is equal to zero, and we will use 𝐼𝐾𝑡𝑜 to denote the 𝐼𝐾𝑡𝑜,𝑓 .
The K+ currents are described by the following equations:
Rapidly inactivating transient outward K+ current (𝐼𝐾𝑡𝑜 ) contributes to the depolarization of
APs. It characterizes the isoforms of the 𝐾𝑣 4.2/𝐾𝑣 4.2, and the model formulation is:
𝐼𝐾𝑡𝑜 = 𝐺𝐾𝑡𝑜 𝑎3 𝑡𝑜 𝑖𝑡𝑜 (𝑉 − 𝐸𝐾 )
𝑑𝑎𝑡𝑜
= 𝛼𝑎 (1 − 𝑎𝑡𝑜 ) − 𝛽𝑎 𝑎𝑡𝑜
𝑑𝑡
𝑑𝑖𝑡𝑜
= 𝛼𝑖 (1 − 𝑖𝑡𝑜 ) − 𝛽𝑖 𝑖𝑡𝑜
𝑑𝑡
𝛼𝑎 = 0.18064𝑒 0.03577(𝑉+30.0)
𝛽𝑎 =0.3956𝑒 0.06237(𝑉+30.0)
𝛼𝑖 =

0.000152𝑒 −(𝑉+13.5)/7.0
0.067083𝑒 −(𝑉+33.5)/7.0 + 1

𝛽𝑖 =

0.00095𝑒 (𝑉+33.5)/7.0
0.051335𝑒 (𝑉+33.5)/7.0 + 1

where 𝐺𝐾𝑡𝑜 is the maximum whole cell conductance (mS/uF), 𝐸𝐾 is the K+ reversal potential, and
𝑎𝑡𝑜 and 𝑖𝑡𝑜 are the activation and inactivation gating variables.
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Rapid delayed rectifier K+ current (𝐼𝐾𝑟 ) is modeled with a Markov model (see Figure 4-2). The
𝐼𝐾𝑟 is presumably encoded by mERG channels with more complex kinetics. The Markov model
includes five states, i.e., CK0, CK1, CK2, OK and IK. The state transitions are regulated by nonlinear
transitions, e.g. 𝛼𝑎0 , 𝛽𝑎0 . Each of these transition rate is function of some exponential equations
[23-24].
𝜶𝒂𝟎
CK0

𝒌𝒇

OK

CK2

CK1
𝜷𝒂𝟎

𝜶𝒊
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Figure 4-2 Markov model of mERG channel.
𝐼𝐾𝑟 is guided by the following equations:
𝐼𝐾𝑟 = 𝐺𝐾𝑟 𝑂𝐾 [𝑉 −

𝑅T 0.98[K + ]0 + 0.98[Na+ ]0
ln(
)]
𝐹
0.98[K + ]𝑖 + 0.98[Na+ ]𝑖

where 𝐺𝐾𝑟 is the conductance (mS/uF), 𝑂𝐾 is the probability of the channel staying in the open
state, 𝑅 is the ideal gas constand, 𝐹 is the Faraday constant, and [K + ]0 and [K + ]𝑖 are the 𝐾 +
concentrations outside and inside the cell [23]. The formulation for calculating [K + ]0 , [K + ]𝑖 and
transition rates can be found in [23].
In addition, the 𝐼𝐾𝑢𝑟 is described by the following differential equations [23]:
𝐼𝐾𝑢𝑟 = 𝐺𝐾𝑢𝑟 𝑎𝑢𝑟 𝑖𝑢𝑟 (𝑉 − 𝐸𝐾 )
d𝑎𝑢𝑟 𝑎𝑠𝑠 − 𝑎𝑢𝑟
=
d𝑡
𝜏𝑎𝑢𝑟
d𝑖𝑢𝑟 𝑖𝑠𝑠 − 𝑖𝑢𝑟
=
d𝑡
𝜏𝑖𝑢𝑟
𝜏𝑎𝑢𝑟 = 0.493 𝑒 −0.0629𝑉 + 2.058
𝜏𝑖𝑢𝑟 = 1200.0 −

170.0
1 + 𝑒 (𝑉+45.2)/5.7

96

where 𝐺𝐾𝑢𝑟 and is the maximum whole cell conductance (mS/uF), 𝑎𝑢𝑟 and 𝑖𝑢𝑟 are activation and
inactivation gates.
The Non-inactivating steady-state K+ current (𝐼𝐾𝑠𝑠 ) is voltage independent ion current, which
is described by the following equations [23]:
𝐼𝐾𝑠𝑠 = 𝐺𝐾𝑠𝑠 𝑎𝑠𝑠 𝑖𝑠𝑠 (𝑉 − 𝐸𝐾 )
d𝑎𝐾𝑠𝑠
𝑎𝑠𝑠 − 𝑎𝐾𝑠𝑠
=
d𝑡
𝜏𝐾𝑠𝑠
d𝑖𝐾𝑠𝑠
=0
d𝑡
𝜏𝐾𝑠𝑠 = 39.3𝑒 −0.0862𝑉 + 13.17
where 𝐺𝐾𝑢𝑟 and is the maximum whole cell conductance (mS/uF), 𝑎𝑠𝑠 and 𝑖𝑠𝑠 are activation and
inactivation gates.
Lastly, the Slow delayed-rectifier K+ current (𝐼𝐾𝑠 ) and Time-independent K+ current (𝐼𝐾1 ) are
determined by the following equations:
2
𝐼𝐾𝑠 = 𝐺𝐾𝑠 𝑛𝐾𝑠
(𝑉 − 𝐸𝐾 )

𝐼𝐾1
4.3

[K + ]0
𝑉 − 𝐸𝐾
= 0.2938( +
)(
)
[K ]0 + 210.0 1 + 𝑒 0.0896(𝑉−𝐸𝐾 )

Materials and Experimental Design

4.3.1 Experimental Protocols and Methods
The cells were held at the resting potential, -70mV, then depolarized by a series of voltage steps
ranging from -50mV to 50mV for 4.5 seconds in 10mV increments. At each clamp voltage the
joint K+ current was collected [6].
The repolarization in adult mouse ventricular myocytes occurs primarily through the action of
all the six K+ ion currents. In in-vitro experiments, the joint K+ current, i.e., the sum of all the six
currents was measured following some pulse protocols. However, as we mentioned before, these
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K+ currents share similar gating kinetics, and it is quite challenging to decompose experimentally
the joint K+ currents. In fact, some of these currents, i.e., 𝐼𝐾1 , 𝐼𝐾𝑠 and 𝐼𝐾𝑟 , are significantly small
and have limited contribution to the joint current. As shown in Figure 4-3, at the clamp voltage of
50mV, the three currents, 𝐼𝐾𝑡𝑜 , 𝐼𝐾𝑢𝑟 and 𝐼𝐾𝑠𝑠 , play significant roles in forming the joint K+ ion
current (𝐼𝐾,𝑠𝑢𝑚 ). It is also shown that the 𝐼𝐾𝑠𝑠 does not exhibit any appreciable voltage-dependence.
In addition, the 𝐼𝐾𝑡𝑜 contributes greatly to the peak of the 𝐼𝐾,𝑠𝑢𝑚 . This gives advantages of
separating the kinetics components mathematically by fitting the decaying portion of the joint K+
current with a bi-exponential function [3,25-28]:
𝑓(𝑡) = 𝐼𝐾𝑢𝑟 𝑒 −𝑡/𝑡𝑎𝑢1 + 𝐼𝐾𝑡𝑜 𝑒 −𝑡/𝑡𝑎𝑢2 + 𝐼𝑆𝑆
where 𝐼𝐾𝑢𝑟 is the amplitude of the ultra-rapidly activating delayed rectifier K+ current of each
current trace, 𝐼𝐾𝑡𝑜 is the amplitude of the rapidly inactivating transient outward K+ current, t is the
time in ms, and 𝑡𝑎𝑢1 and 𝑡𝑎𝑢2 are time constants.
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Figure 4-3 K+ currents at clamp voltage of 50mV.
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To obtain the Steady-State Activation (SSA), the amplitudes of each component for each
current trace, calculated from the bi-exponential function, were divided by the cell capacitance to
generate current density (A/F). The conductance (G) can be obtained through dividing the current
by the reverse potential using the following equation:
𝐺 = 𝐼/(𝑉 − 𝐸𝐾 )
where 𝐼 is the current at each clamp voltage, 𝑉 is the clamp voltage, 𝐸𝐾 is the reverse potential
that is equal to 83.4mV in our in-vitro experiments. Conductance-voltage relationships were fit
with a Boltzmann equation of the form:
𝐺/𝐺𝑚𝑎𝑥 =

1
1 + exp(−(𝑉 − 𝑉𝑎 )/𝐾𝑎 )

where 𝑉 is the membrane potentials, 𝑉𝑎 is the half-activation potential, 𝐾𝑎 is the slope factor. The
normalized data were averaged with those from the other cells to calculate the resulted average G–
V curves.
In the experiments of Steady-State Inactivation, cells were held at -70 mV and then pre-pulsed
to conditioning voltages ranging from -110 mV to 0 mV in 10 mV increments for 10 seconds.
Following the conditioning pulses, the cells were depolarized to 30 mV for 4.5 seconds. The
magnitude of 𝐼𝐾𝑡𝑜 , 𝐼𝐾𝑢𝑟 and 𝐼𝐾𝑠𝑠 generated by each current trace were normalized to their
corresponding peak currents from the pre-pulse, i.e., the first step to 30mV. The data was fit to a
single Boltzmann distribution, from which the mean Vi ± SEM and Ki ± SEM values were
determined. The fraction of maximal currents is:
𝐼/𝐼𝑚𝑎𝑥 =

1
1 + exp((𝑉 − 𝑉𝑖 )/𝐾𝑖 )

where 𝐼/𝐼𝑚𝑎𝑥 is the ratio of each current to the maximum current, 𝑉 is the membrane potential, Vi
is the voltage of half-inactivation, Ki is the slope factor.
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4.3.2 Physical Experiments
Ednie et al. recently reported the effects of ST3Gal4-/- on 𝐾𝑣 channels, showing that ST3Gal4/-

lead to a significant smaller peak density at the clamp voltage of -20mV to 50mV (Figure 4.4a).

This peak current was separated using the method mentioned in Section 4.3.1. The decomposed
𝐼𝐾𝑡𝑜 and 𝐼𝐾𝑢𝑟 were shown in Figure 4-4 b and c. Physical data is provided by Ednie [6]
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Figure 4-4 ST3Gal4-/- alters K+ currents.

4.3.3 Computer Experiments
The computer experiments are aimed at modeling the effects of ST3Gal4-/- on each individual
K+ currents and further predicting the effects on cardiac electrical signaling of ventricular cells.
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First, we modified the 𝐾𝑣 channel gating equations in the detailed ventricular cell models based
on the experimental data shown in the Section 4.2.2. The current density, steady-state activation
and inactivation were optimized to fit the experimental results under both ST3Gal4-/- and WT
conditions. Second, we simulated and compared the variations of each K+ current and cellular APs
with respect to the two conditions. Third, the effects of ST3Gal4-/- on both 𝑁𝑎𝑣 and 𝐾𝑣 channels
are integrated to predict the joint effects on the electrical signaling at the cellular level.
Computer models were implemented using the MATLAB R2014a software from MathWorks
(Natick, MA, USA) in a Windows 7 (Microsoft, Redmond, WA, USA) 64-bit machine. Computer
experiments follow the same pulse protocols as in-vitro experiments to compute the model
responses and to calibrate in-silico models. The models of cardiac cells and 𝐾𝑣 channels are solved
with the use of Ode15s solver at a maximal step size of 1ms.
4.4

Results

4.4.1 ST3Gal4-/- Affects 𝐾𝑣 Channel Activities
The biophysical characterization of 𝐾𝑣 channel gating indicated that the Steady-State
Activation (SSA) of 𝐼𝐾𝑢𝑟 channel was shifted to more depolarized potentials along the voltage axis
under the ST3Gal4-/- condition [6]. The Steady-State Inactivation (SSI) of 𝐼𝐾𝑢𝑟 channel shows
higher inactivation probability when the clamp voltages are greater than 40mV. Figure 4-5 shows
the modeled SSA and SSI. The modeling results are consistent with the in-vitro data, i.e., ST3Gal4/-

shifts the SSA linearly in the depolarized direction, and leads to a delayed de-inactivation at

higher potentials (>40mV).
To further validate the modeling results, the current density of 𝐼𝐾𝑢𝑟 is presented in Figure 4-6.
The in-silico study shows that ST3Gal4-/- contributes to decreased 𝐼𝐾𝑢𝑟 density at smaller, nonsaturating membrane potentials.
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In addition to 𝐼𝐾𝑢𝑟 channel, we also modeled the gating kinetics of 𝐼𝐾𝑡𝑜 channel under both
ST3Gal4-/- and WT conditions. Figure 4-7 shows the in-vitro and in-silico SSA and SSI of 𝐼𝐾𝑡𝑜
channels. ST3Gal4-/- causes a rightward shift in SSA, which indicates that the channel opens at
higher membrane potentials. However, the SSI curve shows no significant difference under the
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Figure 4-7 The 𝐼𝐾𝑡𝑜 gating under ST3Gal4-/- and WT conditions. (a) Steady-state activation (b)
Steady-state inactivation. (In-vitro data as reported by Ednie [6]: ■WT ● ST3Gal4-/-, In-silico
data from the 𝐼𝐾𝑡𝑜 model: straight and dashed lines).
The current density of 𝐼𝐾𝑡𝑜 was also plotted to test the model accuracy. As shown in Figure 48, ST3Gal4-/- leads to a reduced density in 𝐼𝐾𝑡𝑜 current at more depolarized membrane potentials
(>10mV). However, the densities are similar at smaller membrane potentials (-50mV~-10mV)
Note that the discrepancy of current density-voltage relationships between computer models and
experimental data is minimized for both ST3Gal4-/- and WT myocytes. The computer models are
well-calibrated and the result shows that the gating dynamics of 𝐼𝐾𝑡𝑜 channels is different with
ST3Gal4 expression.
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4.4.2 ST3Gal4-/- Affects Cellular Activities
We have also integrated the calibrated models of 𝐾𝑣 channels into the ventricular cell model to
predict whether and how ST3Gal4 gene deletion influence the electrical activity of cardiac cells.
It should be noted that the 𝐾𝑣 channels are responsible for multiple phases of the AP. Slightly
change in each of these 𝐾𝑣 channels may affect the depolarization and repolarization of the
ventricular cell, and contribute to cellular excitation.
Figure 4-9 shows the three K+ currents: 𝐼𝐾𝑢𝑟 , 𝐼𝐾𝑡𝑜 and 𝐼𝐾𝑠𝑠 during a single cardiac cycle and
the AP of ventricular cells. Figure 4-9A indicates that ST3Gal4-/- leads to slower decay in the 𝐼𝐾𝑢𝑟
current. This contributes to slower depolarization among AP (Figure 4-9C). In addition, ST3Gal4/-

promotes an early rise of 𝐼𝐾𝑡𝑜 . Furthermore, The AF of ventricular cells is shown in Figure 4-9C,

where the repolarization of AP is prolonged and leads to a larger AP duration.
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4.5

Conclusions

Mathematical modeling of cardiac myocytes allows one to investigate the detailed disease
mechanisms at molecular levels, i.e. channel level, and predict the effects at other physical scales.
We coupled in-silico studies with the wealth of experimental data to model, mechanistically, how
reduced glycosylation occurring in the ST3Gal4-/- heart affects 𝐾𝑣 activities and cardiac electrical
signaling. The computer experiments showed that ST3Gal4-/- caused decreased current densities
among K+ currents, and delays the repolarization of the AP in ventricular myocytes. This enriches
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the fundamental knowledge of how ST3Gal4 defect leads to cardiac dysfunction and further causes
cardiac arrhythmias. Once mechanistic details on how ST3Gal4 gene deletion contributes to
aberrant electrical signaling in the heart are better understood, potential therapies can be explored
to offset glyco-altered gating in ion channels. Further, new designs of therapies could be suggested
to correct aberrant glycosylation, i.e., potential corrective gene, environmental, and/or metabolic
therapies that could restore the altered cardiac glycome and resume normal cardiac electrical
signaling.
4.6
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Chapter 5 Computer Modeling and Experiments of Electrical Dynamics in Atrial
Fibrillation
Atrial Fibrillation (AF) is a common cardiac arrhythmia that affects more than 5 million
Americans. The impact of AF on healthcare systems is overwhelming, due to high risk of stroke,
increased mortality, impaired quality of life and hospitalization. Catheter ablation is an established
treatment for AF. During the procedure, physicians use the electrodes at the end of catheters to
record electrical activity in the atria (i.e., intracardiac electrogram). Further, cardiologists pinpoint
the potential AF sources and deliver energy through the catheter to create incision lines that block
faulty electrical pathways. However, the understanding of AF initiation and maintenance has
remained sketchy at best. One salient problem is the inability to interpret intracardiac recordings,
which have thus far been unable to reconstruct the rhythmic mechanisms for AF. As a result,
physicians often need to make ablation decisions using ad hoc or heuristic strategies. There is an
urgent need to realize the full potentials of intracardiac electrograms for optimizing ablation
decisions. The objective of this chapter is to develop and calibrate multi-scale computer models of
human atria to simulate fibrillatory conductions that replicate the patterns in clinical recordings.
Specifically, the multi-scale model of atrial cell, tissue and organ are built to investigate AF
behaviors under different scenarios, and the corresponding intracardiac signals are derived. This
research will accelerate the knowledge discovery in the initiation and perpetuation of AF. The
research outcomes will positively impact cardiovascular patients, the largest population at risk of
death in the world.
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5.1

Introduction

Cardiac electrical signaling is an integrative multi-scale system that reflects the orchestrated
functions of ion channels, cell, tissues, and organs. The regular heart activity is initiated at the
sinoatrial (SA) node. Electrical impulse is generated from the SA node and conducted into bother
atria, and then relayed through the antriventricular (AV) node to further propagate through bundle
of His and Purkinje fibers toward ventricular depolarization and repolarization [1]. The recursive
heartbeat is generated by the repeated stimulation originated from at the SA node. Any electrical
impulse initiated at other locations instead of the SA node would disorder the regular heartbeat,
and eventually causes life-threatening heart events [2-3].
Atrial Fibrillation (AF) is the most common type of cardiac arrhythmia and leads to significant
morbidity and mortality. AF is caused by irregular signals that are initiated at another part of atria
other than the SA node or in the nearby pulmonary veins. The abnormal electrical signals spread
throughout both atria in a rapid and disorganized way, which disturbs the normal electrical
conduction and makes the atria to fibrillate. There are two types of mechanisms that have been
identified in triggering and maintaining AF: enhanced automaticity in one or more depolarization,
and reentry involving one or more aberrant circuits [4]. Generally, AF includes three stages:
paroxysmal AF which usually occurs and lasts for seconds, minutes or even hours and stops by
itself; persistent AF which can only be stopped by pharmacological and catheter-based surgical
interventions; permanent AF which cannot be easily stopped by treatments.
Catheter ablation is a common invasive procedure that is frequently used to stop either
paroxysmal or persistent AF. Pulmonary vein isolation (PVI) is one common strategy for rhythm
control in patients with AF. PVI has been proved to be efficient for most paroxysmal AF, but less
efficient for persistent AF. Persistent AF happens because some reentrant spiral waves occur and
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constantly rotate in atria. The reentrant rotor(s) persistently disorders the regular electrical
conduction in the atria. To stop persistent AF, lesions are placed in the left and sometimes right
atrium in addition to the lesions circled around pulmonary vein. However, identifying the location
of lesion is quite challenging because the strategies should be patient-specific and anatomicallybased. It is very critical to correctly target the rotor(s) and avoid the ablation of healthy tissue. In
reality, locating the rotors is very difficult due to the complex and convoluted relationships
between intracardiac electrogram, i.e., the sensor signals collected during AF surgery for
identifying the rotors, and persistence of different patterns, e.g. single rotor, multiple wavelets.
Hence, there is an urgent need to realize the full potentials of intracardiac electrograms for
optimizing ablation decisions. The objective of this chapter is to develop and calibrate computer
models of human atria to simulate fibrillatory conductions that replicate the patterns in clinical
recordings. Specifically, we modeled the AF behavior under different scenarios such as enhanced
automaticity and reentry, and derived the corresponding intracardiac signals of each scenarios. The
research outcomes will accelerate the knowledge discovery in the initiation and perpetuation of
AF, which will positively impact cardiovascular patients, the largest population at risk of death in
the world.
In this chapter, we simulated AF in 2D tissue and surface of 3D atria to linking the potential
mechanisms of AF to the intracardiac signals observed during AF. Section 5.2 presents the multiscale models for simulating different type of AF; Section 5.3 illustrates the design of experiments
and is followed by some experimental results in Section 5.4. Section 5.5 concludes this chapter
5.2

Human Atrial Models

Computer models facilitate the quantitative simulation, elucidation, and understanding of
cardiac function in AF. Simulation studies overcome the practical limitations in clinical practices,
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and enable the investigation of detailed disease mechanisms. This present study builds multi-scale
models of human atrial cell and tissue to examine different AF behavior and the corresponding
intracardiac signals. The development of multi-scale atrial model is described as follows.
5.2.1 Model of Human Atrial Myocyte
The cellular excitation is controlled by the orchestrated function of ion channels. When a
cardiac myocyte is stimulated, The close, activation, inactivation of ion channels allow the ions
(e.g., 𝑁𝑎+ , 𝐶𝑎++ , and 𝐾 + ) to cross the membrane. The influx and efflux of ions form some ionic
currents that further vary trans-membrane potentials. Specific to human atrial cells, a number of
models have been developed in the literature, e.g., the CRN model [5], the Nygren and Fiset model
[6] and the Simitev-Biktashev model [7].
In this present investigation, we utilized CRN model to describe the electrophysiological
behaviors of human atrial myocytes [5]. The justification is that the AP duration (APD) generated
by this model matches clinical observations well. At the same time, the AP waveforms changes
adaptively when cells are excited within the average atrial effective refractory period. Refractory
period is the time that a cell consumes to get ready for the second excitation after the first excitation.
In AF, cells are stimulated frequently by abnormal triggers and rotors, and produce inadequate AP
with shorter AD durations (APD) and smaller magnitudes. Capturing the inadequate AP
waveforms during the AF is essential for modeling different disease behaviors.
The atrial cell of the CRN model includes 12 different types of ion currents, and the membrane
potential 𝑉 is calculated with the following ordinal differential equation [5]:
−𝐶𝑚

𝑑𝑉
= 𝐼𝑁𝑎 + 𝐼𝐾1 + 𝐼𝑡𝑜 + 𝐼𝐾𝑢𝑟 + 𝐼𝐾𝑟 + 𝐼𝐾𝑠 + 𝐼𝐶𝑎,𝐿 + 𝐼𝑝,𝐶𝑎 + 𝐼𝑁𝑎𝐾
𝑑𝑡
+𝐼𝑁𝑎𝐶𝑎 + 𝐼𝑏,𝑁𝑎 + 𝐼𝑏,𝐶𝑎 + 𝐼𝑠𝑡𝑖𝑚

112

where 𝑡 is time, 𝐶𝑚 is the cell capacitance per unit surface area, 𝐼𝑠𝑡𝑖𝑚 is the external stimulus
current which activates the cell from the resting state. The transmembrane currents include
transient outward current (𝐼𝑡𝑜 ), slow delayed rectifier 𝐾 + current (𝐼𝐾𝑠 ), rapid delayed rectifier 𝐾 +
current (𝐼𝐾𝑟 ), inward rectifier current (𝐼𝐾1 ), 𝑁𝑎+ /𝐶𝑎++ exchange current (𝐼𝑁𝑎𝐶𝑎 ), pump current
(𝐼𝑁𝑎𝐾 , 𝐼𝑁𝑎𝐶𝑎 ), plateau currents (𝐼𝑝𝐶𝑎 ), background currents (𝐼𝑏𝐶𝑎 , 𝐼𝑏𝑁𝑎 ), fast Na+ current (𝐼𝑁𝑎 ) and
L-type 𝐶𝑎++ current (𝐼𝐶𝑎𝐿 ). Most of these voltage-gated ionic currents are modeled in the form of
cell conductance, membrane potential gradients and channel gate dynamics. The details of all ionchannel kinetics can be found in references [5]. All parameters and initial values are the same as
was given in the CRN model.
5.2.2 Model of Human Atrial Tissue
Cardiac tissue behaves as a functional syncytium, and electrical waves of depolarization and
repolarization continuously propagate among the tissues. At the cellular scale, each depolarized
cell can stimulate neighboring cells and trigger cell-to-cell conductions. The depolarization of
cardiac myocytes is delayed by gap junctions. When modeling the tissue activity, we make the
assumption that the electrical propagation can be consider as a continuous process, hence we could
simulate the tissue with mathematical descriptions.
In this study, we simulate the electrical propagation in a 1D cable using the following monodomain reaction-diffusion equation:
𝜕𝑉
1
𝜕 2𝑉
(𝐼 + 𝐼𝑠𝑡𝑖𝑚 ) + 𝑔𝑔𝑎𝑝
=−
𝜕𝑡
𝐶𝑚 𝑖𝑜𝑛
𝜕𝑥 2
and in 2D tissue, the equation is:
𝜕𝑉
1
𝜕 2𝑉 𝜕 2𝑉
(𝐼𝑖𝑜𝑛 + 𝐼𝑠𝑡𝑖𝑚 ) + 𝑔𝑔𝑎𝑝 ( 2 +
=−
)
𝜕𝑡
𝐶𝑚
𝜕𝑥
𝜕𝑦 2
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where 𝐼𝑖𝑜𝑛 is the sum of trans-membrane ion currents, 𝑔𝑔𝑎𝑝 is the gap junction between cells. To
simulate the propagation of cardiac electrical waves along 1D fiber, reaction-diffusion equations
are numerically solved with the finite-difference scheme, and no flux boundary condition is
assumed to ensure there are no current leakages on the borders. On the 1D and 2D tissues, the
numerical finite-difference scheme is formulated as:
𝑡
𝑡
𝑉𝑖𝑡+1 − 𝑉𝑖𝑡
1
2𝑉𝑖𝑡 − 𝑉𝑖−1
− 𝑉𝑖+1
(𝐼 + 𝐼𝑠𝑡𝑖𝑚 ) − 𝑔𝑔𝑎𝑝
=−
𝑑𝑡
𝐶𝑚 𝑖𝑜𝑛
𝑑𝑥
𝑡+1
𝑡
𝑡
𝑡
𝑡
𝑡
𝑡
𝑡
𝑉𝑖,𝑗
− 𝑉𝑖,𝑗
2𝑉𝑖,𝑗
− 𝑉𝑖−1,𝑗
− 𝑉𝑖+1,𝑗
2𝑉𝑖,𝑗
− 𝑉𝑖,𝑗−1
− 𝑉𝑖,𝑗−1
1
(𝐼𝑖𝑜𝑛 + 𝐼𝑠𝑡𝑖𝑚 ) − 𝑔𝑔𝑎𝑝 (
=−
+
)
𝑑𝑡
𝐶𝑚
𝑑𝑥
𝑑𝑦

For simplicity, we consider the gap junctions along different directions are identical.
In the 3D surface of the atria, a finite triangular mesh is used to describe the topological surface
of both atria. The heart surface, however, is irregular and cannot be approximated by the same way
as was described above for 2D tissue. Popular treatment for irregular shapes in various engineering
discipline is Finite Element Method (FEM) and similar methods. Unfortunately, typical FEM
technique relies on precise formulation of the problem under Cartesian coordinate systems, often
assuming the independency of net flux along each axis. The problem of interest here is action
potential diffusion along the heart surface, but not homogeneously along the three independent
axes of the Cartesian system that the surface is in. For this reason, FEM does not provide a feasible
approach in this case. To approximate the diffusion process guided by the Laplace Operator over
the surface, one has to start with the fundamental property of the operator to derive the suitable
formula.
By the divergence theorem, Laplace Operator of AP integrated over a surface area 𝐴 is equal to
the line integration of net flux around the close boundary 𝑆 of the surface area 𝐴:

 V dA   FdS
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where 𝑉 is the action potential, 𝐹 is the first order derivative of 𝑉, 𝐴 is the surface area, and the
integration is circled around this surface area along its boundary.
For sufficiently small area, and sufficiently smooth action potential 𝑉 over the surface, we can
approximate the Laplace Operator at a point as the average of Laplace Operator around its vicinity:

V p 

1
FdS
Ap 

where V p denotes the approximated Laplace Operator at a point 𝑃, and Ap is the surface area
around P.
To formulate a FDM-like approximation, we further partition the right-hand-side into n pieces
first, with 𝑛 independent, discrete action potential differential:
V p   FdS 

where

F S

i 1, n

i

i

/ Ap

Fi is the action potential differential and S i is the length of the boundary covered by i’s

sub area (See Figure 5-1 a). Also,

Ap   Ai
i 1,n

where

Ai is i’s sub area. By evaluating this formulation, we are allowed to calculate the circular

integration discretely
Apparently, when we are doing the actual approximation, the selection of the pieces
surrounding the interested point is arbitrary. However, in order to maintain accuracy, one needs to
choose a reasonable set of sub areas. A good choice for triangular mesh is to divide the surface
area around point P into fan shaped sectors (see Figure 5-1 b). Each sector has radius equal to half
length of the edge it was attached to, and spans half of the angle between the two edges besides P.
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𝑃

(a)

(b)

𝐹3

𝐹1

𝐹2

𝐹2

𝐹1

𝑆1
𝑆2

Figure 5-1 Illustration of partial integration in one triangle.
The calculation is based on a few assumptions: (1) We approximate

Fi as the difference of

action potential between two adjacent vertexes divided by the length of the edge linking them.
Because the best estimate of the location where F is equal to this approximation is just half way
along the edge, the sector radius is naturally half of the edge’s length. (2) We assume the other two
points other than P have equivalent weighting when calculating net flux, thus the two sectors have
the same angle. (3) We assume

Fi is always orthogonal toward the arc of the sector. This

eliminates the necessity to calculate the integral along the border between the two sectors.
5.2.3 Intracardiac Electrograms
The intracardiac signals are the most fundamental features for understanding different AF
behaviors and locating rotors and wavelets. In surgery, a catheter is placed on the surface of atrial
wall, and the potentials at each electrodes of the catheter vary while electrical waves pass through.
In this study, catheters are simulated according to the real size and structure in clinical surgery.
The potential at each electrode is calculated using the following equation:
𝐼𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒
𝑑𝑥𝑑𝑦
𝑟
𝑆

∅=∬

where 𝑆 is the area over cardiac tissue, 𝑖𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒 is the transmembrane currents which can be
calculated as:
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𝐼𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒 = 𝐼𝑖𝑜𝑛 + 𝐶𝑚

𝜕𝑉
𝜕𝑡

and 𝑟 is given as:
𝑟 = √(𝑥 − 𝑥𝑒 )2 + (𝑦 − 𝑦𝑒 )2 + 𝑧𝑒 2
where 𝒆 = (𝑥𝑒 , 𝑦𝑒 , 𝑧𝑒 ) is the location of the electrode, 𝑥 and 𝑦 represent the coordinates of cells
on 2D tissue. The 𝐼𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒 current is obtained with the following equation:
𝜕 2𝑉 𝜕 2𝑉
𝐼𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒 = 𝑔𝑔𝑎𝑝 ( 2 +
)
𝜕𝑥
𝜕𝑦 2
∅ gives the signals collected from a single electrode, which is a unipolar signal. In reality, all
recorded signals in the EP laboratory are bipolar. In bipolar catheter, potential differences between
2 electrodes are measured. The potential differences between two electrodes as:
𝐶𝑆12 = ∅(𝑥𝑒1 , 𝑦𝑒1 , 𝑧𝑒1 ) − ∅(𝑥𝑒2 , 𝑦𝑒2 , 𝑧𝑒2 )
It may be noted that 2-3mm distance is considered between each two electrodes.
5.3

Design of Experiments

5.3.1 Experimental Protocols
In this present investigation, we modeled the electrical propagation in AF among atria at
different scales of 1D fiber, 2D tissue and 3D topological atrial surface. The conductance is chosen
to be 1/4000 in the experiments of 1D and 2D cases.
As we mentioned before, stimulation within the effective refractory period could generate
inadequate AP waveforms, which will further lead to insufficient depolarization and repolarization
among atria. The AF could occur because of the propagations of abnormal and disorganized AP
waveforms. In 1D cable experiments, we tested the APD of atrial cells on 1D cable composed of
600 atrial cells at different pacing rate (PR) of 200ms, 300ms, 400ms and 500ms. The temporal
step is 0.01ms, and the spatial distance between every two neighbor cells is 0.1mm. A 2ms
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stimulation (2000pA/pF) is given at the beginning the cable (cell 1-cell 5). Euler method is used
to calculate the electrical propagation among the 1D cable.
In 2D tissue, we construct the model by arranging cardiac cells in an array composed of 600 by
600 cardiac cells. Different stimulation strategies are applied: 1) a 4ms stimulation (2000pA/pF)
with pacing rate of 500ms is given to the upper left corner of the cell array, which triggers a
sequence of electrical waves propagating towards the lower right corner of the tissue. 2) A same
stimulation is given at the middle of upper boundary of the cell array (cell (1,300)), which produces
electrical waves propagating down to the other side of the tissue. 3) The spiral wave was initiated
by applying a first stimulus (S1 = 2 ms) along one side of the tissue to generate a rectilinear wave
propagating toward the other side. When the refractory tail of electrical waves reaches the middle,
a second stimulus (S2 = 2 ms) will be given in the middle of the tissue, paralleling to the first
rectilinear wave and covering only 3/4 of the length of the tissue [9]. The temporal and spatial
steps used in 2D experiments are 0.01ms and 0.1mm accordingly.
In the 3D topological surface of atria, we simulate the electrical propagation on a finite
triangular mesh (Figure 5-2). Stimulation (2ms, 2000pA/pF) with 500ms pacing rate is give at the
Sinoatrial node. The conductance is 1/60 in this current simulation.

Figure 5-2 Finite element mesh of atria.
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All the experiments are implemented on a workstation with an Intel dual core i3-2100 CPU
@3.10GHz and 16G of DDR3 memory. The models of 1D and 2D tissue are solved with the use
explicit finite-difference methods. Computer models were implemented using MATLAB R2012a
software from MathWorks (Natick, MA, USA) in a Windows 7 (Microsoft, Redmond, WA, USA)
64-bit machine.
5.3.2 Catheter Placement
Different types of catheters are used in EP lab, for example ablation catheter, PentaRay catheter.
The structures of catheters vary in sizes and number of electrodes. Figure 5-3 shows the design of
an ablation catheter, where three electrodes and one ablation electrode are embedded on the
flexible polymer body. During the test, catheters will be place against the atrial wall, and each
electrodes could measure one lead of electrical signals, i.e., intracardiac signals. In reality, all
signals collected in the EP lab are bipolar, i.e., the signals constitute a potential difference between
2 electrodes with the distance of 2-3mm. In this study, we simulate the electrode following the
design in reality, and place 4 electrodes with the distance of 2mm-20mm-2mm on the surface of
the 2D tissue. The potential signals were calculated using the equations mentioned in Section 5.2.3.

Electrode
Ablation Electrode

Flexible Polymer Body

Electrodes

Simulated Catheter

Ablation Catheter

Figure 5-3 Structure of the ablation catheter. (Image on the left is from [10], in public domain.)
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5.4

Results

5.4.1 APs at Different Pacing Rates on A 1D Cable
We tested the response of atrial cells in the CRN model to different PR of 500ms, 400ms, 300ms
and 200ms and 100ms on a 1D cable. Figure 5-4 shows the APs of the 300th cell in the middle of
the atrial cable. As shown in Figure 5-4, when stimulation is given every 500ms to the first cell of
the cable, the 300th cell generates slightly smaller AP waveforms with shorter plateau phase
(Figure 5-4 b). When the PR is 400ms or 200ms (Figure 5-4 c and e), cells produced alternant AP
waveforms, i.e., one normal AP followed by one AP with shortened APD lacking plateau phase.
It may be noted that if the PR is equal to 300ms, cells show regular and normal AP waveforms
(Figure 5-4 d). This is because every other stimulation falls into the absolute refractory period,
during which a second stimulus (no matter how strong) will not excite the cell. In this case, the
electrical waves are triggered in every 600ms, and propagate smoothly on the cable. This indicates
the PR and the abnormality of electrical propagation do not follow linear relationship, i.e., smaller
PR is not necessary to be the reason of abnormal electrical propagation among atrial tissue.
However, when PR is equal to 100ms, cells cannot get fully excited all the time (Figure 5-4 e).
The discussion on how PR affects the electrical propagation among atria is important because
abnormal AF waveforms can results in different types of reentry, which further lead to cardiac
tachycardia. The vortices of reentry can be a mechanism of life-threatening cardiac arrhythmias.
5.4.2 Modeling of Atrial Fibrillation on 2D Tissue
AF remains a challenging task because the connection between the intracardiac signals and the
mechanism of AF is missing. Many efforts have been made to study the intracardiac signals either
analytically or statistically, but the progress is limited. This is partially due to scarcity of
information about the ground truth, i.e., the exact mechanism of the AF presented in each patient.

120

In most cases, the information regarding the disease behavior is mainly based on empirical
guessing. The limitation mentioned above makes the validation of the developed analytical
methods quite challenging. In this section, we investigated the relationships between the
intracardiac signals and different types of electrical waves with simulation models.
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Figure 5-4 AP waveforms of 1D cable at different pacing rates.

121

1500

2000

We first simulated the regular electrical conduction on a 6cm by 6cm atrial tissue, and placed
the modeled electrodes on the surface of the tissue to measure the potential signals. The stimulation
protocol is described in Section 5.3.1, i.e., an electrical wave is triggered every 500ms at the upper
left corner of the tissue, and the four electrodes are placed horizontally. When the wave passes
through the four electrodes, sequence of potential signals are collected (Figure 5-5 c). The
difference of the electric potentials collected from electrode 1 and 2, and the difference of the
signals collected from electrode 3 and 4 are calculated to obtain the bipolar data (Figure 5-5 b).
Figure 5 (a) shows the zoom in of the signals, where the electrical wave takes less time while
passing through electrode 1-2 comparing with electrode 3-4, i.e., the time interval between
minimal and maximal value of a single waveform is 4.00ms in the signal collected from electrode
1-2, and is 7.73ms in the signal collected from electrode 34. The intracardiac signals show regular
and recursive patterns (Figure 5-5 b) since the normal electrical waves were generated by pulse
with higher pacing rate.
The patterns of the potential signals highly depend on the locations of the sensors, the angels
between the wave font and the sensor direction, as well as the conduction velocities. Furthermore,
we placed the four electrodes horizontally, and stimulated electrical wave in the middle of the
upper boundary of the tissue (Figure 5-6 c). This generates two leads of intracardiac signals that
are symmetrically identical to each other (Figure 5-6 a).
We also simulated the intracardiac signals measured from spiral wave propagation. Following
the protocols given in Section 5.3.1, spiral waves were generated on the 2D tissue. The electrodes
were placed horizontally on the tissue. Figure 5-7 shows the two leads signals measured by the
sensors. Since the wave frequently passes the electrodes, the potential signals present higher
frequency (~116ms between each two spike).
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Figure 5-5 Simulated intracardiac signals - asymmetric layout of sensors.
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Figure 5-6 Simulated intracardiac signals - symmetric layout of sensors.
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Figure 5-7 Simulated intracardiac signals of spiral wave propagation.

5.4.3 Modeling of Atrial Fibrillation on 3D Topological Surface of Atria
The simulation on the 2D flat tissue indicates very important mechanisms of AF and
intracardiac signals. After all, 2D simulation produces limited spatial information. It is quite
necessary to build 3D models for investigating AF mechanisms and identifying abnormal
activations. Studies have demonstrated that the 2D models are sufficient for simulating the
electrical activities in atria, since atrial walls are thin, and electrical propagation on the surface of
atrial could represent the real signals from the 3D atria.
In this study, we simulated the electrical conduction on the inner surface of both left and right
atria. For simplicity, each point in the finite element mesh represents one atrial cell, and cells are
connected by gap junction. The AP of each cell is calculated using the CRN model described in
Section 5.2.1. Figure 5-8 shows the screenshots of the electrical propagation at 100ms, 600ms,
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1000ms, 1300ms and 1700ms. Two cells, i.e., below the SA node and on the posterior wall, are
selected, and the APs are plotted on the right column. Stimulation is given in every 500ms at the
SA node to generate electrical conductions. Since 500ms is smaller than the effective refractory
period, the atrial cells present alternant AP waveforms.
100ms

Cell 1

Cell 1

600ms

1000ms

Cell 2

Cell 1

1300ms

1700ms

Figure 5-8 Electrical propagation on atria.
125

5.5

Conclusions

AF is a very common cardiac disorder that is associated with high morbidity and mortality. AF
is generally caused by electrical impulses generated from abnormal atrial cells other than the
natural activations. The most common strategy for treating AF is catheter ablation, i.e., lesions are
placed in atria to stop abnormal trigger initiating the fibrillation. However, correctly targeting the
location of the lesions remains challenging because there is lacking of theory that links the
mechanism of AF with the complex intracardiac signals. The challenges are pose by (1) limited
knowledge regarding the real disease behaviors since it is almost impossible to visualize and
observe the electrical propagation among human atrial muscles, and (2) the high complexity of the
intracardiac signals produced by multiple waves propagating in various directions and rotating at
different spots.
Modeling and simulation provide unique opportunity for studying AF mechanisms and
developing efficient approaches of diagnosis. In-silico models can simulate different AF behaviors
and generate the corresponding intracardiac signals. In this chapter, we built multiscale model of
atria and modeled the regular and spiral waves propagating on 1D and 2D tissue. We first test the
APs of 1D cable at different pacing cycles, the results showed the irregular pacing rates can lead
to alternant AP waveform and inadequate AFs, which will potentially cause cardiac tachycardia
and atrial fibrillation. We also derived the intracardiac signals generated by different electrical
propagations. In addition, electrical propagation among 3D atrial surface is simulated, and this
provides a framework for investigating AF mechanisms and developing robust rotor identification
methodologies.
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Chapter 6 Conclusions
Physical experiments are expensive and difficult to conduct, and often encounter many practical
and ethical limitations. These limitations have posed significant challenges for knowledge
discovery and scientific research. Computer experiments and simulation optimization provide an
unprecedented opportunity for addressing those challenges. This research developed innovative
methodologies for modeling and optimizing complex systems, and creates enabling technologies
for improving cardiac healthcare. Specifically, this study integrates physics-based models with
statistical methodologies to improve the understanding of pathological changes in the heart. It
enables and assists in (i) developing a system-level mechanistic understanding of multi-scale
cardiac systems from ions to cells to tissues to the whole heart; (ii) improving the understanding
of disease pathologies and creating better diagnostic/prognostic tools; and (iii) optimizing
pharmaceutical designs and medical treatment planning.
This study integrates in-silico models with the wealth of data from in-vitro experiments to
model and predict glycosylation modulation dynamics of multi-scale cardiac electrical signaling.
This research provides new pharmaceutical targets for the long QT syndrome and potentially other
cardiac disorders.
It is well known that computer models of cardiovascular systems involve greater levels of
complexity such as high-dimensional parameter space, nonlinear and non-convex equations.
Traditional linear and nonlinear optimization methods have encountered many difficulties for

128

model calibration. This research develops a new statistical metamodeling approach for efficient
computer experiments and optimization of large-scale cardiac models.
The results and experience gained from my previous projects lay a solid foundation for my
continued research and innovation. As a next vertical step, my future research will be focusing on
design of experiments and simulation optimization with application in healthcare and systems
engineering. Specifically, the following topics will be interested: Multi-scale physical-statistical
modeling of complex systems with focus on uncertainty analysis; Optimizing cardiac surgical
treatment and planning; Design and analysis of physical and computer experiments for leveraging
in-silico and in-vitro experiments.
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